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“Nanos gigantum humeris insidentes.”
Bernardus Carnotensis
“If I have seen further, it is by standing on the shoulders of giants.”
Isaac Newton
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Abstract
The main risk for patients affected by type 1 diabetes (T1D) is
to fall in hypoglycemia, an event which leads to both short and
long-terms automatic failure and can be life-threatening espe-
cially when occurs at night without subject awareness. Moreover,
T1D patients can develop asymptomatic hypoglycemia, reducing
the prompt response of the counterregulatory system triggered
by the fall in blood glucose. Avoiding hypoglycemia is impor-
tant in children and adolescents because hypoglycemia episodes
may have clinically relevant effects on cognition. Also in adults,
cognitive tests assessed that hypoglycemia results in altered cere-
bral activity, most likely due to the complete dependence of the
brain for glucose supply.
The first organ influenced by this fall of glucose in the blood
is the brain. Indeed, a lot of studies proved the mirroring of cog-
nitive dysfunction due to hypoglycemia in the spectral power
of the electroencephalogram (EEG) signal. In particular, the in-
crease of the power in low frequency EEG bands is a well-known
effect during hypoglycemia that seems more pronounced in the
EEG recording in the posterior areas of the brain. Pilot studies
about the real-time processing of the EEG signal to detect hy-
poglycemia have indicated that it might be possible to alert the
patients by means of EEG analysis. The main advantages in ex-
ploiting EEG analysis is that the blood glucose threshold to enter
in hypoglycemia has large inter-subjects variations, on the con-
trary the EEG onset in general occurs before the state of hypo-
glycemia is critical, i.e., the brain starts to experience neurogly-
copoenia and its functions completely fail.
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The main aim of this work is to broaden out the quantita-
tive analysis on the altered EEG activity due to hypoglycemia
in T1D patients to identify potential margins of improvement in
EEG processing and further features sensitive to hypoglycemia.
In particular, the analyses are extended to different domains, i.e.,
time and frequency domains, to deepen the knowledge on the
effects of hypoglycemia in the brain. So far, studies in the litera-
ture have mainly evaluated these changes only on a single EEG
channel level on the frequency domain, but limited information
is available on the hypoglycemia influence on brain network dy-
namics and on connection between different brain areas. To do
so, this dissertation is structured in 7 chapters, briefly presented
below.
Chapter 1 will start with a brief overview about the impact
of T1D and its main effects on daily life. Moreover, the main
consequences of hypoglycemia in human brain will be described
by reporting the main findings in the literature.
Chapter 2 will present the database where EEG data and blood
glucose samples were collected in parallel for about 8 h in 31
T1D hospitalized patients during an hyperinsulinemic – hypo-
glycemic clamp experiment.
Chapter 3 will address on the main effects of hypoglycemia
in the frequency domain. After testing the well-known changes
in the spectral power of the EEG signal during hypoglycemia, a
multivariate analysis based on the concept of Information Partial
Directed Coherence will be presented. In particular, we will con-
firm the general slowing in the frequency domain and we will
show how hypoglycemia affects the EEG functional connectivity.
Chapter 4 will consider the effects of hypoglycemia on EEG
complexity. Fractal dimension features, describing both ampli-
tude and frequency properties, will be computed and compared
vwith the results based on Sample Entropy. We will reveal a de-
crease of EEG signal complexity in the hypoglycemic condition.
Chapter 5 will focus on the consequences of hypoglycemia in
the so-called microstates or "athoms of thought". We will hypoth-
esize that the changes in the frequency domain and the decrease
of the EEG signal complexity in hypoglycemia have in common
the same resting EEG electric potential amplitude map.
Chapter 6 will describe how hypoglycemia influences the re-
sults of cognitive tests, and the relationship between the drop in
the tests performance and the EEG quantitative measures pre-
sented in the previous chapters. We will find a direct correlation
among the changes in the power spectra, the cognitive tests per-
formance and the changes of one resting EEG electric potential
amplitude map.
Eventually, Chapter 7 will close the dissertation by interpret-
ing the ensemble of the results from both the medical and engi-
neering point of view, and presenting the possible future devel-
opments of this work.
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Sommario
Il principale rischio per i pazienti colpiti dal diabete di tipo 1
(T1D) è cadere in ipoglicemia, un evento che provoca una nu-
trita serie di sintomi ed effetti a breve e lungo termine e può
essere particolarmente pericoloso quando si verifica durante la
notte senza averne coscienza. Inoltre, questi pazienti rischiano di
sviluppare una forma di ipoglicemia senza sintomi, riducendo la
risposta ormonale controregolatoria innescata dalla diminuzione
della concentrazione di glucosio nel sangue. Evitare questo stato
patologico, è particolarmente importante sia nei bambini e ado-
lescenti per evitare possibili distorsioni cognitive, sia negli adulti
dove test cognitivi hanno dimostrato un’alterata condizione cere-
brale durante l’ipoglicemia. Infatti l’ipoglicemia provoca una
diminuzione delle funzioni cerebrali e l’organo maggiormente
affetto da questo stato patologico è il cervello.
Si trovano vari studi in letteratura che provano come la riduzio-
ne delle funzioni cognitive si rifletta in cambiamenti della potenza
spettrale del segnale elettroencefalografico (EEG). In particolare,
la crescita della potenza delle basse frequenza nel segnale EEG è
un effetto ben noto in letteratura. Studi pilota hanno dimostrato
che potrebbe essere possibile utilizzare il segnale EEG per se-
gnalare l’entrata in ipoglicemia. Il maggiore vantaggio è che se
la soglia di concentrazione di glucosio nel sangue è variabile da
soggetto a soggetto, l’onset dei cambiamenti del segnale EEG
avviene solitamente prima che lo stato di ipoglicemia sia così
grave da causare una marcata neuroglicopenia con conseguente
disfunzione cerebrale.
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Il principale scopo di questa tesi è approfondire l’analisi delle
alterazioni del segnale EEG nel T1D causate dall’ipoglicemia per
identificare potenziali margini di miglioramento nell’analisi del
segnale EEG e ulteriori caratteristiche sensibili all’ipoglicemia. In
particolare, le analisi sono estese a diversi domini, il dominio del
tempo e il dominio della frequenza, per approfondire la conoscen-
za sugli effetti dell’ipoglicemia sul cervello. Fino ad ora, gli studi
in letteratura hanno principalmente valutato questi cambiamenti
a livello di singolo canale EEG e nel dominio della frequenza, ma
una limitata informazione è disponibile sull’influenza dell’ipo-
glicemia sulla dinamica della rete cerebrale e sulla connessione
tra le diverse aree cerebrali. Per affrontare questi temi, la tesi è
strutturata in 7 capitoli, brevemente descritti di seguito.
Il Capitolo 1 presenta una panoramica sulle conseguenze e
sull’impatto nella vita di tutti i giorni del T1D. Inoltre, si de-
scrivono brevemente i risultati sugli effetti dell’ipoglicemia sull’at-
tività cerebrale riportati in letteratura.
Il Capitolo 2 riporta il database su cui sono basate tutte le
analisi presentate in questa tesi. Il segnale EEG e la concentrazione
di glucosio nel sangue sono state raccolte in parallelo per circa 8
ore in 31 pazienti ospedalizzati affetti da T1D indotti in ipoglicemia
attraverso un clamp ipoglicemico iperinsulinemico.
Il Capitolo 3 tratta degli effetti dell’ipoglicemia sull’EEG nel
dominio della frequenza. Dopo aver confermato la presenza di
cambiamenti nel valore della potenza del segnale EEG durante
l’ipoglicemia, si riporta un’analisi multivariata basata sulla stima
della connettività funzionale del segnale EEG durante questo stato
patologico. In particolare, confermeremo il rallentamento del
segnale EEG nel dominio della frequenza e dimostreremo come
lo stato ipoglicemico influenza la connettività funzionale del se-
gnale EEG.
Il Capitolo 4 si concentra sugli effetti dell’ipoglicemia sulla
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complessità del segnale EEG. In particolare, le analisi sono basate
su indicatori frattali e sul confronto dei loro valori con i risultati
di indicatori basati sulla definizione di entropia. Riveleremo una
decrescita della complessità del segnale EEG durante lo stato di
ipoglicemia.
Il Capitolo 5 tratta le conseguenze dello stato ipoglicemico
sui microstati, definiti anche "atomi del pensiero". Ipotizzeremo
che i cambiamenti nel dominio della frequenza e la decrescita
della complessità del segnale EEG possano essere originati da
una stessa mappa delle ampiezze del potenziale elettrico del se-
gnale EEG.
Il Capitolo 6 si focalizza sull’influenza dell’ipoglicemia sui
risultati di test cognitivi come lo Stroop test. Inoltre, tratta la
relazione tra il calo nella performance in questi test e le misure
quantitative del segnale EEG presentate nei capitoli precedenti.
Troveremo una correlazione diretta tra i cambiamenti della potenza
spettrale, dei test cognitivi e di una mappa EEG.
Infine, il Capitolo 7 conclude la tesi cercando di interpretare
tutti i risultati nel dominio del tempo e della frequenza sia da un
punto di vista clinico sia da un punto di vista ingegneristico e
presenta i possibili sviluppi futuri.
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1Chapter 1
Hypoglycemia and EEG in
type 1 diabetes
1.1 Type 1 diabetes and Hypoglycemia
1.1.1 The pathology of type 1 diabetes
The 5-10% of people suffering from diabetes are affected by type
1 diabetes (T1D) [1], also called juvenile diabetes because it is
usually diagnosed in children or young adults. Nowadays the
majority of individuals affected by T1D are adults, because of
the rising number of new-onset cases of T1D in adults and the
increased life expectancy for individuals with childhood-onset
diabetes [2]. Type 1 diabetes is most common in Scandinavian
populations and in Sardinia and Kuwait, and much less common
in Asia and Latin America (data are generally lacking for sub-
Saharan Africa and large parts of Latin America) [3]. In the past
few decades, the annual incidence appears to be rising steadily
by about 3% in high income countries [4] [5].
In this kind of disease, the autoimmune destruction of the β-
cells of the pancreas results in the consequent insulin deficiency,
leading to the subsequent increased glucose in blood and urine.
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Insulin is the most potent anabolic hormone known, and pro-
motes the synthesis and storage of carbohydrates, lipids and pro-
teins, while inhibiting their degradation and release into the cir-
culation. Insulin stimulates the uptake of glucose, i.e., the most
important fuel for human metabolism, but also amino acids and
fatty acids into cells, and increases the expression or activity of
enzymes that catalyze glycogen, lipid and protein synthesis, while
inhibiting the activity or expression of those that catalyze degra-
dation [6]. To compensate the lack of insulin secretion, T1D pa-
tients are lifelong dependent on exogenous insulin. For a cor-
rect insulin administration, they need to self-monitor their blood
glucose, diet, physiological insulin replacement, medication, and
lifestyle in order to maintain good glycemic control, avoiding
hypoglycemia, considered one of the most dangerous complica-
tions of diabetes treatment. Although current methods of blood
glucose detection and insulin replacement have improved in the
last years, e.g., by continuous glucose monitoring (CGM) devises
and smart pumps [7], they are still imperfect and the hypoglycemia
risk is high in T1D patients.
The internationally approved definition of symptomatic hy-
poglycemia is an event during typical neurogenic symptoms, such
as shakiness, anxiety, nervousness, palpitations, sweating, dry
mouth, pallor, and pupil dilation, are accompanied by a measure
plasma glucose concentration lower than 70 mg/dl (3.9 mmol l−1).
The huge range of physiological, hormonal, symptomatic and
cognitive responses triggered by the fall in blood glucose are visi-
ble in Fig. 1.1 [8]. All the neurogenic signs are caused by elevated
levels of epinephrine, i.e., the primary fast-acting hormone in the
defense against acute hypoglycemia, besides glucagon. How-
ever, epinephrine responses to hypoglycemia can become im-
paired in T1D [9], leading to hypoglycemia unawareness. Thus,
T1D patients can develop a high risk to fall in asymptomatic
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hypoglycemia, reducing further the efficacy of the counterreg-
ulatory responses to future hypoglycemia: a vicious cycle, Fig.
1.2. Nevertheless, hypoglycemia awareness can be reversed by
avoiding new hypoglycemia episodes, thanks to a strict glycemic
control.
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FIGURE 1.1: Glycemic thresholds for secretion of
counter-regulatory hormones and onset of physio-
logical, symptomatic, and cognitive changes in re-
sponse to hypoglycemia in non-diabetic humans.
Reproduced from [10].
1.1.2 Morbidity and mortality of hypoglycemia
Iatrogenic hypoglycemia causes recurrent physical and psycho-
logical morbidity and some mortality, impairs defenses against
subsequent hypoglycemia, and precludes maintenance of eug-
lycemia, i.e., blood glucose concentration in the range [70 − 180]
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FIGURE 1.2: Schematic diagram of hypoglycemia-
associated automatic failure (HAAF) in diabetes.
Reproduced from [11].
mg/dl ([3.9 − 10] mmol l−1), over a lifetime of diabetes [12]. In
particular, hypoglycemia can have both short-term dangerous
effects, such as cognitive dysfunction, behavioral abnormalities,
confusional state, coma, seizures, transient ischaemic attack and
transient hemiplegia, and long-term effects, such as cerebrovas-
cular events, hemiparesis, focal neurological deficits, ataxia, choreoa-
thetosis, cognitive impairment with behavioral and psychosocial
problems and rarely, epilepsy and vegetative state [13]. To avoid
diabetes complications and to guarantee a high quality of life,
in a good diabetes self-management, special attention should be
paid to diabetes-related distress, fear of hypoglycemia, eating
disorders, insulin omission, subclinical depression, and clinical
depression [2]. Moreover, physical activity and exercise may be
very challenging for T1D patients because of the increasing risk
of hypoglycemia during immediately, following and, about 7–11
h post-exercise, caused by muscles replenishing glycogen stores
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post-exercise [2]. Last, but not least, sleep is a risk factor for noc-
turnal hypoglycemia that is very common, often asymptomatic
and undetected [14]. During night, usual hypoglycemia warning
symptoms and the sympatho-adrenal response are blunted [15],
moreover the intensity of symptoms is diminished when lying
flat [16].
As previously discussed, hypoglycemia has a wide-ranging
clinical effects, but also social and economical in both industri-
alized and developing nations. Indeed, hospitalization of dia-
betic people after a hypoglycemic episode leads to a significant
increase of treatment costs due to an increased length of hospital
stay and a higher risk of all-cause mortality [17]. In conclusion,
avoiding hypoglycemia in T1D is both medically and economi-
cally important.
1.2 Hypoglycemia and the brain
1.2.1 The role of glucose in brain function
Glucose is the main source of energy for human brain and its reg-
ulation is critical for brain physiology [18]. Despite the brain ac-
counts for 2% of body weight, it is the principal consumer of glu-
cose, i.e., 20% of glucose-derived energy [19]. In Fig. 1.3, the role
of the glucose in human brain is summarized. In particular, spe-
cialized centers in the brain, including neurons in the hypotha-
lamus, sense central and peripheral glucose levels and regulate
glucose metabolism (panel A in Fig. 1.3). Glucose supply to the
brain is regulated by neurovascular coupling and may be mod-
ulated by metabolism-dependent and -independent mechanisms
(panel B in Fig. 1.3). Glucose enters the brain from the blood
by crossing the blood-brain barrier (BBB) through glucose trans-
porter 1, and glucose and other metabolites (e.g. lactate, Lac) are
6 Chapter 1. Hypoglycemia and EEG in type 1 diabetes
rapidly distributed through a highly coupled metabolic network
of brain cells (panel C in Fig. 1.3). Glucose provides the energy
for neurotransmission (panel D in Fig. 1.3), and several glucose-
metabolizing enzymes control cellular survival (panel E in Fig.
1.3) [18]. Indeed, glucose is required for both neurotransmitters
synthesis and several glucose-metabolizing enzymes control cel-
lular survival, but the largest amount of glucose is consumed for
neural computation and signal processing, furthermore the brain
increases its glucose consumption upon activation [20]. In partic-
ular, in adult brain, neurons have the highest energy demand and
the BBB that separates the circulating blood from the brain extra-
cellular fluid is highly selective and permeable for glucose. Thus,
glucose is an energy source that is not replaceable for the brain.
1.2.2 Cognition dysfunction during hypoglycemia
The human brain depends on the continuous supply of glucose
and it is vulnerable for any glucose deprivation. For this reason,
the lack of glucose can lead to both-short term and long-term
cognitive dysfunction. For instance, in a 16-year follow-up study
[21], authors proved that T1D subjects early exposure to severe
hypoglycemia episodes may have lasting and clinically relevant
effects on cognition. Indeed, subjects with early severe hypo-
glycemia already had reduced cognitive function in childhood.
Moreover, they also tended to have a less favorable develop-
ment in cognitive function during follow-up compared with con-
trol subjects, in particular in memory (assessed by Rey Auditory
Verbal Learning Test), problem solving and verbal function (as-
sessed by Wechsler Adult Intelligence Scale III), and psychomo-
tor efficiency (assessed by finger tapping). In [22], where cog-
nitive tests, i.e., the California Computerized Assessment Pack-
age, the Stroop test and the Trail Making Test B (TMT B), were
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FIGURE 1.3: (A) Specialized centers in the brain
sense central and peripheral glucose levels and
regulate glucose metabolism. (B) Glucose sup-
ply to the brain is regulated by neurovascular
coupling. (C) Glucose and other metabolites
are rapidly distributed through a highly coupled
metabolic network of brain cells. (D) Glucose pro-
vides the energy for neurotransmission, and (E)
several glucose-metabolizing enzymes control cel-
lular survival. Reproduced from [18]
performed to assess selective attention, visual attention, cogni-
tive alterations, the reaction time and speed of information pro-
cessing in T1D adults during hypoglycemia compared to eug-
lycemia, cognitive function deteriorated as expected during hy-
poglycemia. In the above studies, cognitive tests assessed that
hypoglycemia results in an altered cerebral activity, likely due to
the entirely dependence of the brain for glucose supply. There-
fore, the brain is the first organ to be affected by hypoglycemia
and the decrease of cerebral functioning consequent to this con-
dition may be investigated through suitable analysis of the elec-
troencephalogram (EEG) signal.
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1.2.3 Hypoglycemia-related EEG changes
The EEG signal is the recording from multiple electrodes of the
brain electrical activity made along the scalp in standard loca-
tions according, for example, with the 10/20 International Sys-
tem, where each site has a letter to identify the lobe and a num-
ber to identify the hemisphere, i.e., letters F, T, C, P and O stand
for frontal (yellow area in Fig. 1.4), temporal (blue area), "cen-
tral", parietal (green area), and occipital lobes (orange area), re-
spectively and even numbers refer to electrode positions on the
right hemisphere, while odd numbers refer to those on the left
hemisphere. In Fig. 1.5, a representative example of a sweep of
a single EEG channel recording (P3-A1A2) in the time domain is
depicted: the amplitude is about tens of µV, the signal is not peri-
odic, but has some dominant rhythms. Indeed, in the frequency
domain, the EEG signal can be seen as the sum of simpler parts
characterized by different frequency components as described in
panel (a) in Fig. 1.6: delta waves, from 1 to 4 Hz, characterized
by high amplitude waves; theta waves, from 4 to 8 Hz, that ap-
pear during meditative and relaxed state in adults; alpha waves,
from 8 to 13 Hz, that appear with closing eyes and decrease dur-
ing mental efforts and opening eyes; and beta waves, from 13 to
30 Hz, that represent thinking, active concentration and move-
ments. We can evaluate how the energy of the EEG signal is dis-
tributed with frequency observing its power spectrum, panel (b)
in Fig. 1.6.
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FIGURE 1.4: Brain lobes (upper panel) and stan-
dardize nomenclature and location of electrodes in
the 10/20 International System (lower panel).
FIGURE 1.5: Representative example of a 4-s EEG
sweep from P3-A1A2 derivation in the time do-
main.
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FIGURE 1.6: (a) Main frequency components of
the EEG signal represented in Fig. 1.5; (b) power
spectrum of the same signal.
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Hypoglycemia causes an extensive range of clinical effects
and highly affects the brain functions. Indeed, hypoglycemic
events in patients with T1D are associated with measurable EEG
changes. The first studies aiming to see if cognitive dysfunction
was mirrored by altered EEG activity during hypoglycemia date
back to 40’s: in [23], authors observed abnormal EEG activity
defined as slow potentials, high amplitudes fast potentials and
irregular or disorganized patterns, during hypoglycemia. Then,
also in [24], authors emphasized the importance of blood sugar
concentration on cerebral function, observing EEG dysrhythmia,
i.e., distorted EEG waves with higher amplitude, during hypo-
glycemia, as visible in Fig. 1.7. But hypoglycemia-effect on EEG
was also quantified by the increase of low-frequency slow-wave
activity [25]. For instance, in [26], the hypoglycemic condition
was correlated with an increase in the theta activity in diabetic
children and in [27], pathological activity in both delta and theta
bands was observed in T1D adolescents. This increase in the
power of low frequency bands during hypoglycemia in T1D pa-
tients is a well-established effect in the literature. Indeed, in [28],
authors observed an increase in theta activity set in abruptly at
a mean blood glucose concentration close to 2 mmol l−1. These
changes were symmetrically and diffusely spread over the cortex
though slightly more pronounced in the recordings from the tem-
poral and parieto-occipital areas. In [29], induced hypoglycemia
in eight T1D patients resulted in a significant increase in low fre-
quency electroencephalographic activity, most pronounced over
anterior regions of the brain. After the hypoglycemic period,
EEG activity was normalized immediately. Also in [30], an in-
crease in delta, and especially in theta activity was found by show-
ing a topographic maximum in lateral frontal regions during light
hypoglycemia ([50−60] mg/dl), while during deep hypoglycemia
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(40 mg/dl) there was a topographic maximum of slow frequen-
cies in posterior parts of the brain (centro-temporal to parieto-
occipital regions). In [31], similar results were found in adoles-
cents with T1D, where a history of severe hypoglycemia corre-
lated with a global increase in theta activity, whereas poor metabolic
control correlated with elevated delta activity. Moreover, a de-
crease in fast activity was most pronounced bilaterally in the pos-
terior temporal regions.
EEG in EUGLYCEMIA
EEG in HYPOGLYCEMIA
FIGURE 1.7: EEG signal during euglycemia (up-
per panel) and hypoglycemia (lower panel). Re-
produced from [24].
Given that symptom perception as an estimation of the blood
glucose level can be unreliable, as alternative or, more likely, com-
plement to blood glucose sensors, the use of the EEG signal has
been suggested to detect the entering in hypoglycemia. A re-
search prototype portable device, able to measure the EEG signal
by subcutaneous electrodes and then analyze and classify it in
real-time, has been proposed for the detection of hypoglycemia-
events [32]. This device proposed by Hyposafe was designed to
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detect and alert T1D patients of hypoglycemia before the situ-
ation becomes critical by continuous measurement of the elec-
trical activity within the brain (via EEG) [33]. This technology,
patented in [34], is made by a 5 cm long, 0.5 mm diameter elec-
trode implanted only a few millimeters below the skin, and a
non-implanted device which stores and processes the EEG sig-
nal and contains a power source (18 h), a sound generator and a
light indicator to inform the user of critical events, Fig. 1.8. Thus,
Hyposafe idea is based on using the brain directly as a biosensor,
measuring changes in EEG signals and monitoring for signs of
hypoglycemia. The device can remain implanted for more than
10 years without creating inconvenience to the user. Moreover,
there is no risk of infection or allergic reactions, because there are
not physical elements passing through the skin and the use of
bandage/plaster is not required [33].
The clinical studies of continuous EEG recording and real-
time data processing during insulin-induced hypoglycemia in
T1D patients conducted so far indicate that it might be possible
to predict incidents of severe hypoglycemia before the patients
are severely cognitive impaired both during daytime and sleep,
[33] [35] [36]. Despite several contributions, a systematic evalu-
ation of the effects of hypoglycemia in the brain to identify solid
indicators sensitive to hypoglycemia has not been reported yet.
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FIGURE 1.8: Technology made by a 5 cm long,
0.5 mm diameter electrode implanted only a few
millimeters below the skin, and a non-implanted
device which stores and processes the EEG signal
and contains a power source (18 h), a sound gen-
erator and a light indicator to inform the user of
critical events. Reproduced from [33].
1.3 Aim of the work
Starting from the findings in the literature, the main aim of this
work is to identify potential margins of improvement in EEG pro-
cessing and further features indicators sensitive to hypoglycemia
to deepen the knowledge on the effects of hypoglycemia in the
brain. So far, studies in the literature have mainly evaluated
these changes only on a single EEG channel level on the fre-
quency domain, but limited information is available on the hy-
poglycemia influence on brain network dynamics and on con-
nection between brain different areas. After testing the well-
known effect of hypoglycemia in the spectral power in all the
19 EEG channels, a multivariate analysis is applied (Chapter 3)
to deepen the knowledge on hypoglycemia effects on EEG con-
nectivity. Then, nonlinear indices originally developed for the
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representation of chaotic systems are implemented to provide in-
formation complementary to that obtained by linear methodolo-
gies with a possible improvement of the hypoglycemia detection
(Chapter 4). Furthermore, the different topographical configu-
rations of electric potentials over the multichannel electrode ar-
ray are evaluated both in euglycemia and hypoglycemia to in-
vestigate the changes in brain network dynamics (Chapter 5).
Eventually, the interaction between all the quantitative EEG mea-
sures proposed and the results of behavioral tests are compared
to research the important role of EEG quantitative changes in
neurocognitive functions (Chapter 6). All these methodologies
are tested on a database of T1D subjects who underwent an 8-h
hyperinsulinemic-hypogycemic clamp experiment with the gen-
eral goal of having a more complete overview on the effects of
hypoglycemia in the brain.
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Database
Thirty-one patients 1 with T1D underwent an hyperinsulinemic
– hypoglycemic clamp (described in Section 2.2) with a target of
2.0 − 2.5 mmol l−1. Nineteen patients (58 % males; mean age,
55± 2.5 years; diabetes duration, 28.5± 2.5 years) were recruited
from the diabetes outpatient clinics at Nordsjællands Hospital
Hillerød and Steno Diabetes Center, Denmark, while twelve pa-
tients (67 % males; mean age, 37.5± 3.5 years; diabetes duration,
15 ± 3 years) were recruited from the diabetes outpatient clinics
at Hvidovre Hospital, Denmark. For further details, see Table
2.1. The database was kindly provided by Dr Claus B. Juhl, Dr
Anne-Sophie Sejling, and Dr Christian Frandsen. Hyposafe A/S,
Lynge, Denmark, assisted with providing the data.
2.1 Inclusion criteria
Inclusion criteria were type 1 diabetes for >3 years, age >18 years,
and being either hypoglycemia aware or unaware. Exclusion cri-
teria included pregnancy; breastfeeding; any brain disorder; use
of antiepileptic drugs, β-blocking drugs, or neuroleptic drugs;
use of benzodiazepines within the last month; cardiovascular
disease; and alcohol or drug abuse. Hypoglycemia awareness
1The study was approved by the local ethical committee and the patients
gave written informed consent.
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TABLE 2.1: Database
# Patient ID Awareness status Gender Age (y) Diabetes duration (y)
1) 1 Unaware Female 68 33
2) 2 Unaware Male 65 38
3) 3 Aware Male 45 15
4) 6 Aware Male 56 28
5) 8 Unaware Male 60 15
6) 9 Aware Female 66 33
7) 10 Unaware Male 62 37
8) 11 Unaware Male 55 35
9) 12 Aware Female 45 11
10) 13 Unaware Female 69 45
11) 15 Aware Male 42 16
12) 16 Unaware Male 59 20
13) 19 Unaware Female 52 34
14) 20 Unaware Male 67 23
15) 21 Aware Male 36 18
16) 23 Unaware Female 53 33
17) 24 Unaware Female 45 27
18) 26 Unaware Male 66 54
19) 27 Unaware Female 40 27
20) D6 Aware Female 42 18
21) D9 Aware Male 51 14
22) D12 Aware Male 38 8
23) D15 Aware Male 29 15
24) D18 Reduced awareness Male 40 20
25) D20 Aware Female 36 22
26) D21 Aware Male 22 7
27) D26 Aware Male 66 37
28) D28 Aware Male 28 16
29) D33 Aware Female 26 20
30) D34 Reduced awareness Male 29 15
31) D40 Reduced awareness Female 43 3
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status was classified by the Pedersen-Bjergaard method [37], the
Gold score [38], and the Clarke method [39]. Of the 31 partici-
pants, 13 patients were classified as hypoglycemia unaware and
15 patients as hypoglycemia aware according to all three meth-
ods, while 3 patients as hypoglycemia unaware according to two
methods (labeled with reduced awareness in Tab. 2.1). Patients
who did not qualify as either hypoglycemia aware or unaware
were excluded from the analyses.
2.2 Experimental protocol
For the clamp procedure, insulin (Actrapid; Novo Nordisk, Ballerup,
Denmark) mixed with heparinized plasma from the patient and
isotonic saline was administered intravenously at a rate of 1 mU
insulin/kg/min for the progressive induction of hypoglycemia.
A variable 20% glucose infusion was administered to keep plasma
glucose at the desired levels. During the experiment lasting about
8 hours, blood glucose (BG) samples monitored (Yellow Springs
Inc (YSI), USA) every 5 minutes to individualize at least 1-h of
hypoglycemia (HYPO) and 1-h of euglycemia (EU) and 19 EEG
channels were simultaneously recorded (Cadwell, Easy II, Ken-
newick, USA) using standard cap electrodes placed on the scalp
according to the international 10/20 system, while the patients
were sitting in a chair with eyes open. Offline, EEG was analog-
ically low-pass filtered to avoid aliasing, then digitally acquired
and finally down-sampled at 200 Hz. The dynamic range of the
EEG was±4620 µV with an amplitude resolution of 0.14 µV . The
internal noise level in the analogue data acquisition system was
estimated to be 1.3 µV RMS. In Fig. 2.1, P3-A1A2 EEG chan-
nel recording and simultaneous BG data from a representative
subject are visible. 1-h of EU and 1-h of HYPO and 1-h of recov-
ery after induced-hypoglycemia were individualized by visual
20 Chapter 2. Database
inspection of the BG time-series before and after it crossed the
hypoglycemic threshold of 70 mg/dL.
FIGURE 2.1: Data from a representative sub-
ject during the hyperinsulinemic-hypoglycemic
clamp. On the upper panel, P3-A1A2 electroen-
cephalography (EEG) recordings and on the lower
panel, simultaneous blood glucose concentration
(open circles denote reference YSI samples and
the dashed line denotes their spline interpolation).
Vertical green and red lines refer to 1-h EU- and
HYPO-glycemic and Recovery intervals.
Furthermore, two different cognitive tests were performed in
EU (pre and post induced-hypoglycemia) and HYPO: Trail 5 B
of the Comprehensive Trail Making Test (TMT B) and the Stroop
tests.
2.3 Behavioral tests
2.3.1 Trail Making Test
The Trail Making Test is a neuropsychological test of motor speed
and visual attention composed by two parts. In part A, i.e., TMT
A, the subject’s task is to quickly draw lines on a page connecting
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TABLE 2.2: TMT B
Group Age [years] Score [s]
25-34 50.68± 12.36
35-44 58.46± 16.41
45-54 63.76± 14.42
55-59 68.74± 21.02
25 consecutive numbers without lifting the pen from the paper. If
the patient makes an error, it is pointed out immediately and it is
allowed the patient to correct it. The performance is assessed by
the time taken to complete the trial correctly. In part B, i.e., TMT
B, it is tested how fast the participant can connect numbers and
letters in alternating increasing sequence (i.e., 1-A-2-B, etc.). TMT
B is 56 cm longer and has more visually interfering stimuli than
TMT A. Part B is more difficult than Part A not only because it is
a more difficult cognitive task, but also because of its increased
demands in motor speed and visual search [40]. Thus, TMT B
evaluates visual attention, motor speed, and cognitive alterna-
tion. In Tab 2.2, an example from [41] of the mean time necessary
to complete TMT B stratified by age is reported.
2.3.2 Stroop test
The Stroop tests evaluate processing speed and selective atten-
tion. Specifically, in the Danish version of the Stroop Color and
Word Test by Golden [42], the participant must name as many
items as possible in 45 s at three different conditions: color names
printed in black (Stroop word), blocks printed in different col-
ors (Stroop color), and color names printed in non-matching col-
ors (Stroop combi) [43]. The Stroop test proved how the brain
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slows down if it has to deal with conflict information. For in-
stance, to complete the last task is more challenging than the first
ones because of the brain processing delay caused by the inter-
fering information of color names printed in non-matching color.
Moreover, the more the capacity to direct attention is fatigued,
the harder this last stage becomes. In Fig. 2.2, the effect of in-
terfering word stimuli upon naming colors serially is reported
as the mean time for a group of one hundred students (results
reproduced from one of the original studies of J. Ridley Stroop
[44]).
FIGURE 2.2: The means of the times for the NC
(Naming colors) and NCWd ( Naming the Colors
of the Print of Words Where the Color of the Print
and the Word are Different) tests for a group of
100 students and for each sex are presented with
the difference, the probable error of the difference,
the reliability of the difference, and difference di-
vided by the mean time for the naming color test.
Reproduced from [44].
23
Chapter 3
Frequency domain features
3.1 State of the art
An association between hypoglycemia and EEG changes has been
proved in many works in the literature. Indeed, the EEG signal
reflects the metabolic state of the brain during the critical state
of hypoglycemia. In [45], authors provide a review of the cur-
rent literature regarding changes in the EEG during episodes of
low blood glucose. An increase in the total EEG power and a
generalized slowing of the frequency are seen symmetrically in
all cerebral regions and occur irrespective of age, diabetes dura-
tion, awareness status, or antecedent episodes of hypoglycemia.
More specifically, an increase during hypoglycemia in both the
power of theta and alpha band is indicated in [46] [47] [48] [49]
[50]. Moreover, the centroid frequency (CF) of theta band is of-
ten increased, while the CF of alpha band is reduced [51]. These
changes (summarized in Tab. 3.1) in EEG signals can be qualita-
tively appreciated by visual inspection of the representative data
in Fig. 3.1, in which 5-s segments measured in EU are shown with
those recorded in the same subject when he or she is exposed
to HYPO. At the single-channel level, EEG in HYPO (Fig. 3.1 D
and G) shows higher amplitudes in the low-frequency bands and
greater regularity than the one in EU (Fig. 3.1 C and F). While as-
sessing the synchronization of pairs of EEG sweeps in the same
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TABLE 3.1: Overview of studies investigating hy-
poglycemia EEG changes in the last decade
Study Year N aware
unaware
Powertheta CFtheta Poweralpha CFalpha
[46] 2016 8 nd ↑ → ↑ ↓
[47] 2016 19 nd ↑ ↑ ↑ →
[22] 2015 23 9
14
↑ → → →
[48] 2014 19 nd ↑ ↑ ↑ →
[52] 2013 5 nd ↓ ↑ ↑ ↓
[49] 2013 9 3
6
↑ nd ↑ nd
[50] 2012 35 6
28
↑ → ↑ ↓
[53] 2010 6 nd → ↑ → ↓
[30] 1996 14 7
7
↑ ↑ ↓ ↓
[51] 1996 14 7
7
↑ nd ↓ ↓
↑ increase in HYPO; ↓ decrease in HYPO; → no change; nd not determined
glycemic condition by visual inspection is challenging, calling for
the use of multivariate analysis tools.
Although the notion that hypoglycemia affects EEG rhythms
is well established, limited information is available on if and how
hypoglycemia influences the connectivity between different brain
areas. To the best of our knowledge, existing publications have
focused on univariate EEG studies and in [54], connectivity was
assessed with phase coherence [55], phase lag index [56], syn-
chronization likelihood [57], and phase slope index [58] show-
ing a decline in patients with T1DM (N = 119) respect to con-
trols (N = 61), but it was not shown what happens in HYPO
respect to EU. Over the last twenty years, a lot of parametric and
non-parametric connectivity methods describing the interactions
between cortical areas by the direction and the strength of the
information flow have been proposed [59] [60], and their perfor-
mance compared [61] [62]. Here, after reporting the changes in
the power and centroid frequency in all T1D patients, we used a
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multivariate approach called information partial directed coher-
ence (iPDC) to quantify the functional connectivity between EEG
channel-pairs in EU and HYPO conditions. In particular, iPDC is
computed through the use of multivariate autoregressive (MAR)
models of T3-A1A2, T4-A1A2, T5-A1A2, T6- A1A2, P3-A1A2, P4-
A1A2, Pz-A1A2, C3-A1A2, C4-A1A2, Cz-A1A2, O1-A1A2, and
O2-A1A2 EEG channels recordings in 19 T1D subjects. The value
of iPDC in both the theta and alpha bands was examined when
passing from EU to HYPO.
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Euglycemia Hypoglycemia
Representative subject
5-s EEG sweep during hypoglycemia5-s EEG sweep during euglycemia
5-s EEG sweep during euglycemia 5-s EEG sweep during hypoglycemia
A
B
C D
E
F G
FIGURE 3.1: Data from a representative sub-
ject during the hyperinsulinemic-hypoglycemic
clamp: (A) blood glucose concentration (open cir-
cles denote reference YSI samples; the dashed
lines denote their spline interpolation) and simul-
taneous raw (B) C4-A1A2 and (E) O1-A1A2 elec-
troencephalography (EEG) recordings. Vertical
green and blue lines refer to 1-h EU and HYPO-
glycemic intervals, respectively. For each glycemic
condition, 5-s EEG sweeps are shown (C and D)
for C4-A1A2 and (F and G) for O1-A1A2, where t
= 0 is the sweep start time.
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3.2 Methods
3.2.1 EEG spectral power
A frequency analysis was performed for 5-min EU and HYPO
intervals, using a Welch’s power spectral density (PSD) in delta
([1-3.4] Hz), theta band ([4.8-7] Hz), alpha ([9-12] Hz) and beta
([14-17] Hz) frequency bands. In particular, PSD was found us-
ing Welch’s overlapped segment averaging estimator: the signal
is divided in 4-s sections to obtain segments 50% overlapped.
Each segment is windowed with a Hamming window. Then,
the segments periodograms are averaged to obtain the PSD es-
timation. Then, both absolute and relative power in all four fre-
quency bands were estimated from the averaged PSD. In partic-
ular, relative power was obtained by diving the absolute power
in each band by the total power in the range [1-40] Hz. Thus,
for each subject two vectors (1 x 19) containing the power for
each EEG channel in not overlapping delta, theta, alpha, and beta
bands were obtained in both EU and HYPO conditions. Even-
tually, to assess for each subject and each channel, whether or
not the changes in the absolute and relative power value were
statistically significant when passing from EU to HYPO, paired
Student’s t-tests were computed under the hypothesis of normal
distribution of samples (Lilliefors test) otherwise, Wilcoxon rank-
sign tests were considered (a value of p < 0.05 was considered
significant).
3.2.2 EEG centroid frequency
For each 5-min EU and HYPO intervals, the CF, i.e., the center
of gravity of each frequency band that subdivides the area under
the spectral curve into two of equal size, was also computed. In
particular, the CF was calculated in each band, i.e., delta, theta,
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alpha and beta, and it was assessed for each subject and each
channel, if or not the CF value were statistically significant when
passing from EU to HYPO, paired Student’s t-tests were com-
puted under the hypothesis of normal distribution of samples
(Lilliefors test) otherwise, Wilcoxon rank-sign tests were consid-
ered (a value of p < 0.05 was considered significant).
3.2.3 EEG-based functional connectivity
The functional organization of the brain is characterized by seg-
regation and integration of information being optimally processed.
Functional interactions seem to be provided by synchronized ac-
tivity, both locally and between distant brain regions. Brain net-
works thus consist of spatially distributed but functionally con-
nected regions that process information [63]. In such a context,
functional connectivity (FC) is defined as the temporal depen-
dency of neuronal activation patterns of anatomically separated
brain regions. FC reflects statistical dependencies between dis-
tinct and distant regions of information processing neuronal pop-
ulations [63]. In the multivariate analysis of biomedical signals,
especially for EEG, several methods have been proposed to eval-
uate FC [64] [59], for example through computing cross-correlations
in the time or frequency domain, mutual information or spectral
coherence. FC captures patterns of statistical dependence [65],
but it is well known that statistical dependency is a necessary
yet not sufficient condition for causality [66]. Granger causality
is a widely used data-driven approach to assess the connectivity
among different brain regions and to determine the directional
causal interaction among EEG signals [67]. Several variants of
Granger causality have recently been applied to neurophysiolog-
ical data to gain insight in the direction of influences between
neural systems [68].
3.2. Methods 29
Information Partial Directed Coherence (iPDC)
In this chapter, we chose iPDC to evaluate the mutual relation
between the EEG channels for three main reasons.
1. Estimates of connectivity based on MAR models are robust
to the high contribution of noise in EEG signals.
2. iPDC, in contrast to coherence, considers if the dependence
from two signals comes from the influence of a third one
which drives them.
3. Eventually, iPDC allows assessing directionality.
The iPDC has been recently presented by Takahashi et al [69],
as an improvement of partial directed coherence [68] and gen-
eral partial directed coherence [70]. Indeed, iPDC is considered
more stable than other approaches in FC assessment when sig-
nals have large differences in their amplitudes, as happens with
EEG in hypoglycemia compared with EEG in euglycemia in our
case study. iPDC is a multivariate spectral measure to compute
the directed influences between any given pair of signals (i,j) of
a multivariate dataset. This information is condensed in a com-
plex function iPDCi←j(f) of the frequency f , which measures
the relative interaction of the signal j with regard to signal i as
compared with interactions of all j’s with other signals in the
multivariate dataset. Although we refer the reader to Takahashi
et al [69] for the mathematical details, the following two steps
briefly describe the procedure for computing iPDC.
In the first step, an MAR model is identified by fitting it against
EEG data streams acquired from L different channels. Formally,
letting x(n) :
x(n) = [x1(n), x2(n), ..., xL(n)]
T n = 1, 2, ..., N (3.1)
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(where T stands for transpose) be the vector containing the sam-
ples at the n-th sampling instant n (n = 1, ...N ) of the L con-
sidered EEG channels x1, x2, ..., xL, the MAR model of order p is
described as:
x(n) = −
p∑
r=1
Arx(n− r) + w(n) (3.2)
where Ar r = (1, ..., p) are LxL unknown matrices of model co-
efficients, and the L-size column vector w(n) is the innovation
process with covariance matrix ΣW [69]. The matrices Ar r =
(1, ..., p) and ΣW are estimated by least squares exploiting the so-
called Yule–Walker equations [71]:

Rxx(0) Rxx(−1) · · · Rxx(−p+ 1)
Rxx(1) Rxx(0) Rxx(−p+ 2)
... . . .
...
Rxx(p− 1) Rxx(p− 2) · · · Rxx(0)


AT1
AT2
...
ATp
 = −

Rxx(1)
Rxx(2)
...
Rxx(p)

(3.3)
where the Rxx(k) matrices are the covariance matrices computed
from the available EEG data as
Rxx(k) = {
1
N
∑N−1−k
n=0 x(n)x
T (n+ k) k = 0, 1, ..., N − 1
1
N
∑N−1
n=−k x(n)x
T (n+ k) k = −(N − 1),−(N − 2), ...,−1
(3.4)
In Eq. 3.2 model order p is found by trail until the Akaike
information criterion (AIC) index
AIC(p) = N ln |ΣW |+ 2L2p (3.5)
(where || denotes the matrix determinant) is minimized [72].
In the second step, having defined the complex matrix B(f) as
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B(f) = IL −
p∑
r=1
Are
−j2pif (3.6)
where IL is the identity matrix and j is the imaginary unit in this
equation, the iPDC complex function from the time-series j to the
time-series i is obtained by
iPDCi←j(f) = σ
−1/2
Wu
bij(f)√
bHj (f)Σ
−1
W bj(f)
(3.7)
where bj(f) and bij(f) are, respectively, the j-th column and the
(j, i)-th element of matrix B(f), σWu is the (i, i)-th element of the
innovation covariance matrix ΣW , and the apex H in bHj stands
for the Hermitian transpose (i.e., obtained from bj by taking the
transpose and then the complex conjugate of its components).
The complex function iPDCi←j(f) of Eq. 3.7 is usually analyzed
in terms of its absolute value [69].
iPDC computation
The analysis was applied to 15 min of the EU and HYPO inter-
vals 1. L = 12 EEG channels were considered, and each 15-min
interval of EU and HYPO was divided in 5-s sweeps, resulting
in N = 1000 samples per sweep, a quantity sufficient to obtain
stable results according to Florin et al [73]. At the same time, 5-
s intervals are narrow enough to invoke pseudo-stationarity as-
sumptions on EEG (e.g., as done by Abásolo et al [74] ). For each
sweep, an MAR model as in Eq. 3.2 was identified. Regarding
the model order p, we first considered, for each sweep, the value
minimizing AIC(p) of Eq. 3.5 among candidate orders ranging
from 1 to 20; then, among the estimated values of p, we chose the
1This analysis was applied to the first 19 T1D patients of Tab. 2.1, because
only these data were available when this method was implemented.
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highest and used it as the model order for all sweeps under anal-
ysis for a given subject (the resulting p was always 9 or 10). The
rationale behind this decision is that, to detect coupling direc-
tions in multivariate oscillatory systems, the MAR model should
have a high order [75], and at the same time, overestimating the
model order is better than underestimating it [73]. Then, for any
pair (i, j), the function iPDCi←j(f) of Eq. 3.7 was computed in
theta ([4–8] Hz) and alpha ([8–13] Hz) bands for each sweep.
Eventually, the absolute mean profiles iPDCi←j(f), referred to
the whole interval of 15 min, were computed by averaging the
absolute values of the iPDCi←j(f) profiles estimated in the 5-s
sweeps (throughout this chapter, for sake of brevity, the symbol
iPDC will be used without explicitly showing the dependence
on frequency and channel pair).
iPDC values analysis
Because the values of iPDC can be pretty low, it is necessary, be-
fore evaluating changes passing from EU to HYPO, to determine
an analytical threshold exploiting surrogate data. In particular,
15-min surrogate data in EU and HYPO were obtained randomly
changing the time order of a set of real data (i.e., randomly per-
muting in temporal order the samples of the original series and
so maintaining mean, variance, and histogram distribution of the
original data) [76]. Then, as for real data, iPDC was estimated,
and two thresholds for EU and HYPO, respectively, were calcu-
lated as 5% of the absolute value of iPDC [77]. Thus, before ap-
plying the statistical tests to evaluate if there were remarkable
changes passing from EU to HYPO, it was checked if iPDC re-
sults were above the threshold estimated at any frequency. Even-
tually, to assess for each subject whether or not the changes in
the absolute value of iPDC were statistically significant when
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passing from EU to HYPO, paired Student’s t tests were com-
puted under the hypothesis of normal distribution of samples
(Lilliefors test); otherwise, Wilcoxon rank-sign tests were consid-
ered (a value of p < 0.05 was considered significant). After that,
for each subject, the average value of iPDC was computed to ob-
tain a scalar indicator for the EU and HYPO intervals. This scalar
indicator (which subsequently in this chapter will be denoted by
the symbol iPDC) is obviously much simpler to handle than the
function iPDC for the analysis.
3.3 Implementation
3.3.1 Preprocessing
As far as the analyses of the EEG power and the CF, for each
subject, a pre-analysis was developed considering, in each sub-
ject, two intervals referred to as EU and HYPO, respectively, tar-
geted from the available BG data. In particular, for each sub-
ject, two 1-h intervals corresponding to EU and HYPO condi-
tions, respectively, were identified from the BG time-series by
visual inspection detecting when the glycemic thresholds at 70
and 180 mg/dL were crossed by a smoothing spline approxima-
tion of the samples. Then, 5-min intervals in both EU ([70-180]
mg/dL) and HYPO (<70 mg/dL) conditions were selected. EEG
data in EU and HYPO were band-pass filtered between 1 and 40
Hz using a 4-order Butterworth filter; Independent Component
Analysis was applied in order to remove cardiac and oculomotor
artifacts (only components with clear eye blinks, saccades and
cardiac artefacts were excluded). EEG signals were re-referenced
to the common average-reference.
Concerning the iPDC analysis, as previously described, only
EEG channels in the temporal, central, parietal, and occipital lobes
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(i.e., the L=12 EEG time-series referred to, respectively, as the
T3-A1A2, T4-A1A2, T5-A1A2, T6-A1A2, P3-A1A2, P4-A1A2, Pz-
A1A2, C3-A1A2, C4-A1A2, Cz-A1A2, O1-A1A2, and O2-A1A2
channels) were considered because their analysis is simplified
from the virtual absence of artifacts (e.g., eye-induced, muscle
activation-induced). EEG data were not band-pass-filtered be-
fore computing iPDC in order to avoid possible distortions in the
results [73]. A pre-analysis selected by visual inspection 15-min
intervals in both EU ([70-180] mg/dL) and HYPO (<70 mg/dL)
conditions from BG time series (smoothed by a spline approxi-
mation of the samples).
3.4 Results
3.4.1 Power spectra results
Representative randomly chosen 1-s EEG sweeps are depicted
in Fig. 3.2 to appreciate in all channels, albeit qualitatively, dif-
ferences of the EEG signal in EU (in panel (a)) and HYPO (in
panel (b)). As apparent as in Fig. 3.1, the EEG in HYPO shows
higher amplitudes in the low frequency bands and greater regu-
larity than the one in EU.
As far as the frequency-domain analysis is concerned, the av-
erage relative power in theta (Fig. 3.2 panel (d)) band confirms
the higher amplitude of low-frequency EEG rhythms during hy-
poglycemia with respect to euglycemia in all electrodes (p < 0.0263).
Actually, considering the whole population of subjects, the rela-
tive power in alpha (Fig. 3.2 panel (e)) band shows a statistically
significant increase when passing from EU to HYPO in parietal
and occipital lobes (p < 0.0023). Eventually, a significant decrease
is seen in beta band in all electrodes (p < 0.0357). While, there
were not significant differences in delta band.
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3.4.2 Centroid frequency results
In line with the reported results in the literature, the CF tends
to decrease in the alpha band [51]. In particular, a statistically
significant slowing of the CF during HYPO respect to EU was
found in T4-A1A2 (p = 0.03), T6-A1A2 (p = 0.02), and O1-A1A2
(p = 0.02) in alpha band. In Fig. 3.3, the boxplots for the CF
values in the above cited EEG channels are reported.
3.4.3 iPDC results
The absolute values of the iPDC function iPDCi←j(f) computed
in two 5-s representative sweeps are shown in Fig. 3.4 for a rep-
resentative participant in both the theta (left panel) and alpha
(right panel) bands before (thin upper line) and after entering in
hypoglycemia (thick lower line). The absolute values of iPDC
are rather low but above the computed thresholds (dashed lines)
that indicate the minimal level of iPDC considered as null. Re-
markably, a very visible change passing from EU to HYPO can be
observed in both bands. All the other sweeps referred to this par-
ticipant showed iPDC profiles for all combinations of channels
qualitatively similar to those of Fig. 3.4. The same, on average,
happens in the entire database of subjects.
Considering the function iPDC , it tends to decrease when
passing from EU to HYPO in both theta and alpha bands in all
combinations of the considered EEG channels. An example of
results is documented in Fig. 3.5, which displays, for the rep-
resentative subject, iPDC from T5-A1A2 to C3-A1A2 and from
O1-A1A2 to C4-A1A2 in the theta band (left panels) and from
O1-A1A2 to T4-A1A2 and from O1-A1A2 to C4-A1A2 in the al-
pha band (right panels) in EU (thin upper line) and HYPO (thick
lower line). Considering the entire dataset, in the theta band the
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function iPDC significantly decreases (p < 0.01) in 17 of 19 sub-
jects from T5-A1A2 to C3-A1A2, from O1-A1A2 to C4-A1A2, and
from O2-A1A2 to Cz-A1A2. In the alpha band it significantly de-
creases (p < 0.01) in 17 of 19 subjects from O1-A1A2 to T4-A1A2
and from O1-A1A2 to C4- A1A2.
In Fig. 3.6 we report a boxplot of the values, obtained from
the entire pool of subjects, of the scalar indicator iPDC for the
eu and hypoglycemic intervals. In particular, iPDC from O1-
A1A2 to C4-A1A2 tends to decrease (p < 0.01) passing from EU
to HYPO, and its variability tends to decrease passing from EU
to HYPO.
Because of iPDC changes in HYPO, it is interesting to as-
sess, albeit in a preliminary fashion, the potential discriminatory
power of a classifier driven by iPDC. To do so, we exploited
iPDC from O1-A1A2 to C4-A1A2 related to the 17 subjects in
whom iPDC significantly decreased passing from EU to HYPO.
These values were used to train a support vector machine clas-
sifier (with a gaussian radial basis function kernel with a scal-
ing factor of 1.108). In particular, using the leaving-one-out ap-
proach, 16 out of 17 observations were used as the validation set,
and the remaining observation was used as the training set (each
observation includes iPDC in both the theta and alpha bands for
each subject). This step is repeated on all ways to cut the original
sample.
Classification resulted in 12 of 17 euglycemic events (true-
negative rate) and in 13 of 17 hypoglycemic events (true-positive
rate) correctly estimated, corresponding to a specificity of 71%, a
sensitivity of 76%, and an accuracy of 74%. These classification
results are in line, if not slightly better, than those reported in pre-
vious EEG studies in HYPO [78] [79]. Iaione and Marques [79]
reported an overall accuracy rate of 71.3%, sensitivity of 71.1%,
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and specificity of 71.5% in seven subjects during EU and spon-
taneous HYPO, and Nguyen et al [78] showed a sensitivity and
specificity of 75% and 60%, respectively, in five T1D patients dur-
ing an overnight clamp.
The classification performance from iPDC resulted in a sen-
sitivity and specificity higher than those obtained by us, on the
same database, by applying univariate analysis exploiting the in-
tegral of the power spectral density, the integral of the logarithm
of the squared power spectral density, the centroid frequency
[50], and the reactivity index [80]. Both sensitivity and specificity
in the hypodetection did not exceed 63%.
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FIGURE 3.2: 1-s EEG signals during (a) EU and (b)
HYPO in a representative subject and EEG rela-
tive spectral power topography in EU and HYPO
averaged across all T1D patients in all frequency
bands. During HYPO, there is: (c) not a signifi-
cant power difference from EU in delta band [1-
3.4] Hz; (d) a significant increase in theta band[4.8-
7]Hz in all electrodes (p < 0.0263); (e) a signifi-
cant increase in alpha band [9-12] Hz in parietal
and occipital lobes (p < 0.0023); (f) a significant
decrease in beta band [14-17] Hz in all electrodes
(p < 0.0357).
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FIGURE 3.3: (From left to right) Centroid fre-
quency in T4-A1A2 (p = 0.03), T6-A1A2 (p =
0.02), and O1-A1A2 (p = 0.02) in EU and HYPO
in alpha band.
FIGURE 3.4: Information partial directed coher-
ence (iPDC) in a representative subject. The ab-
solute value of iPDC from O1- A1A2 to C4-A1A2
was computed from a randomly chosen 5-s sweep
in the (left panel) theta and (right panel) alpha
bands in EU (thin upper line) and HYPO (thick
lower line).
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FIGURE 3.5: The information partial directed co-
herence function (iPDC) in a representative sub-
ject. The iPDC is estimated (left panels) from
T5-A1A2 to C3-A1A2 and from O1-A1A2 to C4-
A1A2 in the theta band and (right panels) from
O1- A1A2 to C4-A1A2 and from O1-A1A2 to T4-
A1A2 in the alpha band in EU (thin upper line)
and HYPO (thick lower line).
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FIGURE 3.6: The scalar indicator of the informa-
tion partial directed coherence function (iPDC)
from the entire pool of subjects (n = 19). Box
plots are shown of iPDC from O1-A1A2 to C4-
A1A2 in EU and HYPO in (left panel) theta and
(right panel) alpha bands from all subjects. In each
box the central line is the median value, the edges
of the box are the 75th and 25th percentiles, the
whiskers extend to the most extreme data points
that are not outliers, and the crosses plotted indi-
vidually stand for the outliers.
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3.5 Discussion
In this chapter, we focused our attention on the effect of HYPO in
the frequency domain. In particular, we found an overall increase
of power in theta band and an occipital and parietal increase of
power in alpha band compensated by a parallel overall decrease
of power in beta band during HYPO respect to EU. The general
slowing in alpha band was also confirmed by a statistically sig-
nificant shifting of the centroid frequency during HYPO respect
to EU. However, the changes induced by HYPO influenced also
the results in the EEG functional connectivity. iPDC tended to
decrease when passing from EU to HYPO in both theta and al-
pha bands in all combinations of the considered EEG channels.
These preliminary findings corroborate the hypothesis that the
altered cerebral activity caused by HYPO is reflected by a gen-
eral slowing in the frequency domain.
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Analysis of complexity
4.1 State of the art
For the scope of detecting important dynamical properties of the
physiological phenomena which are hidden in the EEG data dur-
ing hypoglycemia, nonlinear methods can provide information
complementary to that obtainable by linear methodologies, with
a possible improvement of the performance. A particular prob-
lem of biological time series analysis comes from the fact that sta-
tistical characteristics can vary with time. Frequency domain pa-
rameters give assessment of the autonomic function, but the reli-
ability of spectral power diminishes with the decrease in power
signal and signal-to-noise ratio [81]. Many studies, e.g. [82],
showed the decrease of EEG complexity in physio-pathological
and impaired consciousness condition, proving the usefulness
of complexity tools to increase the knowledge on these altered
states. Applying nonlinear complexity indexes to analyze hypo-
glycemia-associated EEG changes might provide new insights
into the effects of HYPO on the brain and support neurophysiolo-
gists in understanding more in depth the functioning of the brain
during HYPO. However, to the best of our knowledge, applica-
tion of nonlinear indicators to the specific problem includes only
the investigation reported in [48], where a decrease of EEG com-
plexity (here intended as irregularity) was shown to be induced
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by hypoglycemia by computing the sample entropy index (Samp
En) at various scale factors, employing the so-called multiscale
entropy algorithm (MSE) [83]. While entropy-based algorithms
are very popular and powerful for analyzing biomedical signals
[84] [85] [86] [82] [87] [88] [89] [90] [91] [92] , their high compu-
tational cost required, in particular for SampEn, may render its
use unsuited for a hypothetical real-time application aimed at
detecting hypoglycemic events from EEG. The aim of the present
chapter is to assess if nonlinear indexes originally developed for
the representation of chaotic systems, such as the fractal dimen-
sion, and already used in the literature to investigate EEG signal
complexity [93] [94] [95], and two new indices reflecting both sig-
nal amplitude and frequency properties [96] are as sensitive as
SampEn to HYPO and may thus lead to the same conclusions, in
terms of signal characteristics, with lower computational cost, i.e.
linear versus quadratic. In particular, we investigate how EEG
complexity can be assessed through features extraction based on
Higuchi’s fractal dimension [97], and we compare its computa-
tional cost with SampEn. However, as demonstrated in several
works, e.g. [98], EEG signal complexity can be assessed using
various methods, with different degree of computational burden.
The methods proposed in this chapter could be of practical rel-
evance, because a reduced computational cost can allow the si-
multaneous computation of more features and/or the grouping
of multiple assessments temporally consecutive.
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4.2 Methods
4.2.1 Sample Entropy
Before focusing on fractal dimension measure, a brief overview
on SampEn is presented. To calculate SampEn for an evenly sam-
pled time-series {s(k)}, k = 1, 2, ..., N , a positive integer m (pat-
tern length) is first chosen. Then, (N˘m) m-dimensional vectors
xm(i) with i = 1, 2, ..., N −m, are defined as
xm(i) = [s(i)...s(i+m− 1)]T (4.1)
where i-th vector xm(i) is made up of m consecutive elements
picked up from the original time-series, starting from the i-th el-
ement. Given a positive real tolerance parameter r, the quantity
Cmi (r), for each i = 1, 2, ..., N −m, is defined as
Bmi (r) =
# of vectors xm(j), j 6= i : d[xm(i), xm(j)] ≤ r
N −m− 1 (4.2)
where, in the numerator, j ranges from 1 to N −m and the quan-
tity d[xm(i), xm(j)], representing the distance between two vec-
tors, is defined for k = 1, ...,m as
d[xm(i), xm(j)] = max(|s(i+ k − 1)− s(j + k − 1)|) (4.3)
and is equal to the absolute value of the difference between corre-
sponding elements of the two considered vectors having, among
the others, the greatest value. For each i = 1, 2, ..., N−m, the ratio
that appears in Eq. 4.2 is obtained dividing the number of vectors
xm(j) having a distance from xm(i) lower than the tolerance r by
the overall number of comparisons (that is equal to N − m − 1,
because j = 1, 2, ..., N − m and the comparisons are performed
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for i 6= j. The mean value over i of the logarithms of Bmi (r) is
then calculated:
Bm(r) =
1
N −m
N−m∑
i=1
Bmi (r) (4.4)
and the quantity Bm(r) is defined. Increasing the vector length
from m to m + 1, the quantity Am(r) is obtained as well, and,
eventually, SampEn is calculated as
SampEn(s,m, r) = −lnA
m(r)
Bm(r)
(4.5)
The computational complexity of the SampEn algorithm is O(N2)
because two loops are required, one forBm(r) and one forBm+1(r).
As a development of SampEn, the MSE approach may be con-
sidered to investigate the complexity of a time-series, assessing
how its entropy varies at increasing temporal scales [83] [82] [99]
[100] [101] [102] . In brief, from the original time-series {s(1), s(2), ..., s(N)},
a new time-series {y(j)τ} is defined as
yτ (j) =
1
τ
jτ∑
i=(j−1)τ+1
s(i), 1 ≤ j ≤ N
τ
(4.6)
where the integer positive parameter τ represents the chosen time
scale. Then, SampEn is computed for several values of τ .
MSE(s, τ,m, r) = SampEn(yτ ,m, r) (4.7)
In practice, the MSE approach reduces the length of the origi-
nal time-series by averaging τ consecutive samples belonging to
non-overlapping blocks. This coarse-graining procedure allows
obtaining averaged down-sampled versions of the original time-
series, whose SampEn values are related to the complex fluctu-
ations of the original signal running at temporal scales τ times
larger than the sampling time used to acquire the data. At a scale
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factor of τ , the execution time required to calculate the SampEn of
the coarse-grained time series is O((N/τ)2). Therefore, the over-
all computational complexity of the MSE approach, at n increas-
ing temporal scales is O(
∑n
τ=1(N/τ)
2). In Fig. 4.1, an example
of the application of MSE in T1D subjects is reported. SampEn
value increases at small time scales (τ from 1 to 5) and monoton-
ically decreases as the time scale becomes larger (τ from 5 to 40),
with a slope steeper at medium temporal scales (τ from 5 to 20)
than at the largest ones (τ from 20 to 40). The initial increase in
the entropy values could be related to the fact that the MSE proce-
dure initially produces an effective decorrelation of a signal with
a finite correlation time [103]. However, as the analyzed tem-
poral scale increases, the number of averaged samples increases
as well, and erratic fluctuations of the signal are attenuated, in-
ducing a progressive entropy decrease, suggesting that the long-
range temporal correlations of the EEG, which are strictly related
to its complexity, are degraded at low BG levels and damaged in
HYPO [48].
4.2.2 Features extraction based on fractal dimension
concept
The fractal dimension provides a complexity index that describes
how the measure of the length of a curve L(k) changes depend-
ing on the scale k used as unit of measurement. Different ap-
proximation techniques can be used to estimate fractal dimen-
sion [104]. Among these different approaches, Higuchi’s algo-
rithm [97] is often employed in EEG analysis to estimate the frac-
tal dimensionD [94] [95] [105]. The Higuchi’s standard approach
calculates fractal dimension of time series in the time domain,
and is based on the log(L(k)) vs log(k) curve computed as fol-
low:
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FIGURE 4.1: Multiscale entropy (MSE) profiles ob-
tained within EEG in T1D patients in EU (green
line with solid circles) and HYPO (blue line with
solid squares) with m = 2 and r = 0.3. Data are
mean± sd values. Stars on the top of the bars indi-
cate statistically significant differences (p < 0.05)
between sample entropy (SampEn) values at the
considered temporal scale. Reproduced from [48]
• For each sample i of the EEG epoch S, absolute differences
between the values S(i) and S(i−k) (i.e. samples at distance
k) are computed, considering k = 1, ..., kmax;
• Each absolute difference is multiplied by a normalization
coefficient that takes into account the different number of
samples available for each value of k. The computation of
this coefficient is based on the starting point m = 1, ..., k
and on the total number (N ) of samples of an epoch;
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• L(k) is computed by summing the obtained values and di-
viding by k;
L(k) =
1
k
k∑
m=1
[
1
k
(
q∑
i=1
|S(m+ ik)− S(m+ (i− 1)k)|)N − 1
qk
]
(4.8)
where q = int[(N −m)/k];
• The log[L(k)] vs log(k) curve, referred in the following as lk,
is finally derived.
By definition, if L(k) is proportional to k−D (i.e. log(k) and
log[L(k)] have a linear relationship) for k = 1, 2, ..., klin, then the
curve is fractal with dimension D. Consequently, klin is the max-
imum k for which L(k) is proportional to k−D and D is estimated
by ordinary least squares as the linear coefficient of the regression
line of the lk curve for k = 1, 2, ..., klin. Therefore, the Higuchi’s
fractal dimension increases as the signal irregularity increases.
The non-linear part of the lk curve (k > klin) presents an oscil-
latory behavior whose characteristics depend on the periodicity
of the signal itself [96]. In Fig. 4.2, the effect of signal period-
icity on Higuchi’s curve is represented for a cosine wave with
frequencies 2.5 Hz (panel a), 5 Hz (panel b) and 7.5 Hz (panel
c) and adding pseudo-normal random noise (sd = 0.2) to the co-
sine wave with frequency 2.5 Hz (panel d). In panels e-h, it can be
seen that the first part of the curve is approximately linear, while
the remaining part presents oscillations (i.e. negative spikes with
respect to the linear fit) that depend on the frequency of the orig-
inal signal, with higher frequency resulting in a larger number of
negative spikes. The presence of additive noise (panel h) slightly
affect the curve, indeed the presence and latency of its negative
oscillations is preserved.
In addition to Higuchi’s fractal dimension, we also extract
two additional features [96], which consider a wider domain of
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FIGURE 4.2: Examples showing the effect of signal
periodicity on Higuchi’s curve. The upper pan-
els show the original signals, generated as cosine
waves with frequencies 2.5 Hz (A and D), 5 Hz
(B) and 7.5 Hz (C). The lower panels (E-H) show
the corresponding Higuchi’s curve. The last sig-
nal (D) is generated adding pseudo-normal ran-
dom noise, with standard deviation equal to 0.2,
to the cosine wave with frequency 2.5 Hz.
the lk curve with respect to the Higuchi fractal dimension. The
first additional feature evaluates the deviation (i.e. the sum of
squares of the residuals) of the lk curve from the regression line
computed on its linear region. The second additional feature is a
tortuosity measures τ of lk. It consists in a measure of the rate
at which the curve is changing with respect to its coordinates
changes (x = log(k) and y = log(L(k))), by using their first and
second partial differences:
τlk =
kmax∑
n=3
∣∣∣∣∣∆x(n)∆2y(n)−∆2x(n)∆y(n)[(∆x(n))2 + (∆y(n))2]3/2
∣∣∣∣∣ (4.9)
where ∆x(n) = x(n) − x(n − 1), ∆2x(n) = ∆x(n) − ∆x(n − 1),
∆y(n) = y(n) − y(n − 1), ∆2y(n) = ∆y(n) − ∆y(n − 1). A
complete description of this tortuosity measures can be found
in [106]. These two features increase as the signal regularity and
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periodicity increase.
The linear region is here defined considering klin = 6, according
to [94], while the two other features are computed considering
also the non-linear region up to kmax = 30 according to [96].
4.3 Implementation
The analysis is applied to P3-C3 EEG derivation in order to com-
pare our fractal dimension indicators to SampEn results obtained
in [48] and it is also evaluated on the same database of [48].
4.3.1 Preprocessing
For each subject, from the two 1-h intervals corresponding to
EU and HYPO conditions, the P3-C3 EEG derivation was chosen
since the EEG signal from this scalp position is highly affected by
hypoglycemic events [30] [35]. The P3-C3 EEG derivation in EU
and HYPO was split into epochs of 4 seconds length, with 2 sec-
onds overlap. Epoch length and overlap were chosen as a trade-
off between the amount of available data samples required to cal-
culate the features for each epoch and the readiness required for
prompt identification of a physiological change.
EEG data can be affected by several sources of noise, such as
body movements and propagation of bioelectrical muscles po-
tentials, which are likely to sum up into the electroencephalo-
graphic signal generated by the brain. Consequently, recorded
EEG signals may show trends, low frequency oscillations and
baseline changes due to these components. In order to remove
these artefacts a detrending step to each EEG epoch was applied
to correct drifts and linear trends. Briefly, a first order model con-
sisting of an offset plus a linear trend was fitted to each epoch, es-
timated and then subtracted from the epoch itself. Furthermore,
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for each epoch, if the value of one or more of its samples was
greater than 100 µV or lower than -100 µV , the epoch was con-
sidered as affected by artefacts and thus not considered for the
analysis (on average, 0.4% epochs rejected per subject).
4.4 Results
For each 4-s EEG epoch in EU and HYPO, the fractal dimension
features described in the previous section were computed. More-
over, the results obtained by the fractal analysis were compared
with the SampEn results (m = 2, r = 0.3) obtained in [48] on
the same dataset, where the 1-h EEG intervals in eu- and hypo-
glycemia were divided in 60 epochs lasting 60 seconds (12000
samples) to guarantee that the shortest analyzed time-series (τ =
40) consisted of at least 300 samples. Indeed, SampEn was de-
rived by coarse-grained time series, obtained by calculating the
arithmetic mean of τ neighboring values without overlapping,
thus reducing the original time- series by a scale factor τ . In
[48], the difference between EEG SampEn in EU and HYPO was
relevant with no scale factor and at the largest temporal scales
(τ = 25 : 40). Thus, we chose τ = 1 (i.e. no scale factor, the
original time series was not decimated) and τ = 35 (i.e. the scale
factor that allowed the most relevant difference between the two
glycemic states) for the comparison of SampEn with our results.
We refer the reader to [48] for further parameter details in Sam-
pEn computation.
The proposed features based on fractal dimension show dif-
ferent distributions in the two glycemic states, denoting a de-
crease in the EEG signal complexity in all the subjects during
HYPO. Indeed, as visible in Fig. 4.3 for a representative subject
where the distributions of the features in EU (green distribution)
and HYPO (blue distribution) are reported, the Higuchi’s fractal
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dimension tends to decrease shifting from EU to HYPO, while
the fractal dimension residuals and tortuosity tend to increase.
These results are confirmed across all subjects, Fig. 4.4.
FIGURE 4.3: Distributions of the values for 4-s
epochs in EU (green distribution) and HYPO (blue
distribution) of Higuchi’s fractal dimension (left),
the residuals (middle) and tortuosity (right) for
the representative subject id 13.
The indices obtained from both the eu- and the hypoglycemic
state were compared by a two-sided Wilcoxon rank sum test to
identify significant changes in the signal properties in two 1-h in-
tervals corresponding to EU and HYPO. A statistically significant
decrease of the standard Higuchi fractal dimension was found
from eu- to hypoglycemic state in 18 over 19 subjects (p always <
2e-22, except for subject with id 27, for which p = 0.248). A statis-
tically significant increase for all subjects was found for residuals
and tortuosity features (p < 4e − 6 and p < 0.005, respectively).
The decrease of Higuchi fractal dimension and the increase of
the two additional features in HYPO highlight a reduction of the
EEG signal complexity in this physiological condition. Moreover,
this reduction of signal irregularity agrees with the progressive
entropy decrease highlighted by the monotonically decrease in
SampEn values in EEG signal affected by HYPO, found in [48].
Thus, all analyzed methods agree in associating a reduction of
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FIGURE 4.4: Distributions of the values for 4-s
epochs in EU (green distribution) and HYPO (blue
distribution) of Higuchi’s fractal dimension (left),
the residuals (middle) and tortuosity (right) for all
subjects.
the irregularity of EEG signal to the hypoglycemic state, which is
in agreement with the progressive loss of cognitive function and
altered cerebral activity.
Receiver operating characteristic (ROC) analysis was performed
to quantitatively measure the capability of each feature to iden-
tify changes in the signal properties related to the different glycemic
state. For each subject, the ROC curve was computed by plotting
the true positive rate (sensitivity) versus the false positive rate (1-
specificity), and the area under the curve (AUC) was measured.
The AUC is a measure of how well a parameter can distinguish
between two groups: it can vary from 0 to 1 and if equal to 1 in-
dicates maximal sensitivity and specificity, and thus perfect dis-
crimination between the two glycemic states. AUCs were cal-
culated for Higuchi fractal dimension, residuals and tortuosity
features. In Fig. 4.5, the results of ROC analysis for all subjects
are depicted. The AUC scores obtained by the features based on
fractal dimension on the majority of the subjects denote their ef-
fectiveness in extracting useful information with discriminatory
power from the EEG signal. A two-sided Wilcoxon rank sum
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test was applied to compare the AUCs obtained by the different
features, and no statistically significant difference was found be-
tween features (p > 0.18).
FIGURE 4.5: Results of the ROC analysis. Area
Under the Curve (AUC) obtained by each feature
for all subjects is reported. In each box, the central
thick line is the median value, the edges of the box
are the 75th and 25th percentiles, the whiskers ex-
tend to the most extreme data points that are not
outliers. Each AUC is also plotted individually.
In order to quantitatively compare the results obtained by the
fractal analysis with that obtained as in [48], AUCs were also de-
rived from the SampEn values obtained in [48] from 60 epochs
lasting 60 seconds with no scale factor (τ = 1) and at a scale
factor τ = 35 (Fig. 4.5). Similar AUC values were obtained
by the different methods, and no statistically significant differ-
ence (p > 0.36) was found between the AUCs obtained from 4-s
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epochs by each fractal feature versus the AUCs obtained from 60-
s epochs by SampEn. A comparison between the fractal features
and SampEn on epochs of the same length was not performed
because 4-s epochs (N = 800) do not contain enough samples to
accurately compute SampEn at different scale factors, and on 60-s
epochs (N = 12000) the computational cost of fractal features and
of SampEn with no scale factor would be too high for a real-time
application.
The computational cost of EEG complexity estimation assessed
by fractal analysis from 4-s epochs (N = 800 samples) is O(KN).
Indeed, the computation of L(k), see Eq. 4.8, requires the execu-
tion of N mathematical operations for each k = 1 : K, with K
smaller than N (in this work, K = klin = 6 for Higuchi’s frac-
tal dimension, K = kmax = 30 for residuals and tortuosity, and
K = kmax = 30 for all of them simultaneously). The short epochs
length and the low computational cost allow fractal features to
provide frequent assessment of the physiological state, which is
essential for a useful real-time detection of HYPO.
On epochs of the same length (4 seconds), entropy based meth-
ods, i.e. SampEn, could be applied without a scale factor, but
their computational cost,O(N2), would be extremely higher than
the one of fractal analysis. This computational cost can be drasti-
cally reduced using SampEn at a scale factor τ , O((N/τ)2). How-
ever, this requires a greater number of samples [107], that in-
volves longer epochs, i.e. 60-s epochs (N = 12000). The high
number of samples to be simultaneously analyzed makes it dif-
ficult to be implemented in a real-time application and the long
time interval of each epoch can potentially affect the readiness to
identify the hypoglycemic state.
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4.5 Discussion
The present chapter investigated if algorithms based on Higuchi’s
fractal dimension can reveal changes in the complexity of the
EEG signal induced by HYPO. Using the P3-C3 EEG derivation
data, we showed that the proposed features based on fractal di-
mension could be used to assess changes in EEG complexity, which
occur during HYPO, likely related to progressive loss of cogni-
tive function and altered cerebral activity. The information con-
tent of these indices leads to results in line with that achieved by
nonlinear entropy-based indicators like SampEn. Indeed, the de-
crease of the Higuchi fractal dimension and the increase of the
residuals and the tortuosity features highlight the same decrease
of the EEG signal complexity in HYPO condition.
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Chapter 5
Microstate analysis
5.1 State of the art
It is interesting, for a better understanding of brain functioning in
hypoglycemia, to investigate further approaches which consider
several EEG channels at the same time. In particular, the aim
of this chapter is to better understand the changes in brain net-
work dynamics that lead to the theta and alpha power increase
during hypoglycemia by performing topographical EEG analy-
sis. By displaying the resting EEG electric potential amplitude of
all channels as a topographic voltage map at each time point, it
is possible to define the series of quasi-stable topographic config-
urations, which last several tens of milliseconds [108] [109] [110]
[111]. In particular, Lehmann was the first to observe that the
topography of the map representing resting EEG electric poten-
tial amplitude does not randomly and continuously change, but
remains stable for a length of time and then abruptly changes
into a new configuration and so on [108]. Moreover, he proposed
that these stable maps were the basic blocks of the information
processing and baptized the term functional microstates for these
athoms of thoughts. The topographies of the microstates are simi-
lar among different studies: 4-8 classes of topographies are usu-
ally identified to explain most of the data [112]. For instance, in
[113], authors presented normative microstates data for resting
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EEG obtained from a database of 496 subjects between the age of
6 and 80 years. Fig. 5.1 shows the topographies of the four mi-
crostates classes which were found in the study arranged in the
following order: microstate class A with a left occipital to right
frontal orientation, class B from right occipital to left frontal, class
C with a symmetric occipital to prefrontal orientation and class D
symmetric, but with a frontocentral to occipital axis. Map areas
of opposite polarity are arbitrarily coded in red and blue using
a linear color scale, left ear is left, nose is up. The four topogra-
phies extend over wide scalp areas and are likely to represent
global brain electric events. From these microstates classes, sev-
eral parameters can be extracted, e.g., the mean duration, i.e.,
how each microstates class lasts before abruptly changing in the
following map. In Fig. 5.2, the duration across age of the mi-
crostates classes of Fig. 5.1 are reported: the mean duration was
circa 80-100 ms and microstates class C dominated during ado-
lescence. Thus, EEG seemed to be able to measure these resting
states as well as the other imaging procedures such as functional
imaging [114], but also with an higher temporal resolution (ms)
[112] with the final aim to understand how the brain works.
FIGURE 5.1: Normalized mean equipotential con-
tour maps of the four microstates classes (A–D)
from study [113]. Reproduced from [113]
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FIGURE 5.2: The duration across age for each map
of the four dominant microstates of the study [113]
is shown. The mean duration is circa 80-100 ms.
Microstate class C dominates during adolescence.
Reproduced from [112]
Indeed, these different topographical configurations of elec-
tric potentials over the multichannel electrode array, i.e., the dif-
ferent microstates, are thought to be related to different func-
tional resting state networks as known from fMRI. Many stud-
ies have discovered significant changes in the resting-state mi-
crostates series in a variety of neuropsychiatric disorders [115]
[116] [117] and behavioral states [118] [119]. To understand how
EEG microstates correlate with parameters extracted using ana-
lytical methods, e.g., relative power in the canonical frequency
bands, is still an open question. Since several works have proven
that a power increase in the low frequency EEG bands takes place
during HYPO with respect to EU (Chapter 3) and differences in
terms of signal complexity have been also evidenced (Chapter 4),
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in this chapter we investigate if there are significant differences
in the time-course of microstates in HYPO compared to EU in the
broadband, delta, theta, alpha and beta frequency range.
5.2 Methods
5.2.1 Averaged topographies
The analysis is based on a two-stage process to obtain the pro-
totype topographies, which best explain most of the signal vari-
ance, in EU and HYPO. The following analysis was performed in
data filtered in broadband [1-40] Hz, in delta, theta, alpha, and
beta frequency bands by a 4-order Butterworth filter. First, for
each patient, the time points of the maximum Global Field Power
(GFP), i.e.,
GFPc(t) =
√∑N
i=1(ci(t)− c(t))2
N
(5.1)
where ci(t) is the voltage potential at the electrode i and c(t)
is the average voltage potential of all electrodes at time point t
and N = 19 is the number of electrodes, were selected as the
moments of high global neuronal synchronization, from EU and
HYPO (Fig. 5.3 panel (a)). For each patient, the topographies of
these time points (Fig. 5.3 panel (b)) were then clustered inde-
pendently using a k-means clustering approach (Fig. 5.3 panel
(c)). The optimal number of clusters was selected based on the
overall performance of multiple clustering validity criteria [110]
[111] [120] [121] [122] [123] [124] [125].
In second step, the optimal clusters of each patient in EU
and HYPO were again clustered together to find the most com-
mon templates maps across the two glycemic conditions. Finally,
these most common templates were fitted back to the original
EEG in EU and HYPO, and each time point twas labeled with the
5.2. Methods 63
cluster maps based on Global Map Dissimilarity (GMD) measure
GMD(t) =
√√√√ 1
N
N∑
i=1
(
ci(t)− c(t)
GFPc(t)
− vi(t)− v(t)
GFPv(t)
)2
(5.2)
where ci(t) is the voltage potential at the electrode i and c(t) is the
average voltage potential of all electrodes at time t in the map c
while vi(t) is the voltage potential at the electrode i, v(t) is the
average voltage potential of all electrodes at time t in the map v
and N = 19 is the number of electrodes. The GMD is equiva-
lent to the spatial Pearson’s product-moment correlation coeffi-
cient between the potentials of the template map and the instant
topography. This resulted in the microstates sequence (Fig. 5.3
panel (d)). Microstates analysis was performed with the freely
available CARTOOL software [126]. In Fig. 5.3, this steps are
schematized: for each time point (a), the potential distribution
map was calculated (b). Then a k-means cluster analysis was
applied to all maps. A cross-validation criterion identified four
dominant maps (c). Fitting these maps back to the original data
revealed that each map appeared repeatedly and dominated dur-
ing certain time segments, i.e., the microstates. These microstates
are color-coded in the curve of Global Field Power at the bottom,
and marked by letters under this curve; they were classified ac-
cording to the standard microstates classes (d).
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FIGURE 5.3: Qualitative example of microstates
segmentation of EEG signal in both glycemic
states using the cluster analysis.
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5.2.2 Microstates parameters
To compare the microstates sequences between EU and HYPO,
the following parameters were computed:
1. the total time coverage (TTC) giving the percent of total
time in the EEG recording, covered by each microstate class,
2. the global explained variance (GEV) for each microstate class,
calculated as the sum of the squared spatial correlation,
weighted by the GFP at each time point, and giving a ratio
of how well the template topography describe the whole
data set [126] and,
3. the Occurrences/s describing the average number of ap-
pearances for the same microstate per second.
Finally, a MANOVA was performed on the results of microstates
parameters for each frequency band, after checking all MANOVA
hypotheses (normally distribution of all dependent variables by a
Lilliefors test, linear relationships between them by scatter plots,
and homogeneity of variance and covariances by Box’s M test).
In particular, the Pillai’s trace criterion was exploited because it is
considered the most powerful and robust, also if the homogene-
ity of covariances is not verified. If the MANOVA revealed a sig-
nificant multivariate main effect, Student’s t tests with p-value
corrected by false discovery rate (Benjamini–Yekutieli procedure
[13]) were applied between the microstates parameters results in
EU and HYPO.
5.3 Results
The averaged topographies obtained following the procedure de-
scribed in the previous sections are reported in Fig. 5.4. In par-
ticular, the analysis for both glycemic conditions in all subjects
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results in four topographies from all the frequency bands. These
four topographies were named map A, B, C and D, according to
the microstates literature convention. In Fig. 5.4, only the to-
pography’s relative configuration, but not its polarity is consid-
ered. These four template topographies are displayed per defi-
nition with red color towards the front. The light-blue squares
highlight maps with significant difference of microstates param-
eters between EU and HYPO: specifically, map D displays sig-
nificant difference in its microstates parameters in all frequency
bands. Moreover, after looking at all the maps topographies in
Fig. 5.4, we can note that map D remains stable in all the fre-
quency bands, i.e., there are not differences in the configuration
of this map across the frequency bands.
In Table 5.1, multivariate tests results of MANOVA applied to
microstates parameters results, i.e., TTC, GEV and Occurrences/s
(compound effect) in EU and HYPO (group effect) for all T1D
patients are reported. After testing that there was a significant
difference in the results of microstates parameters in HYPO com-
pared to EU, results of microstates parameters for both glycemic
conditions in all subjects from data filtered in all bands are com-
puted and depicted in Fig. 5.5. In particular, during HYPO, there
were:
• an increase of Occurrences/s of map C (p = 0.0071) and a
decrease of TTC, GEV and Occurrences/s of map D (p <
0.01) in the broadband;
• an increase of TTC, GEV and Occurrences/s of map B (p <
0.0081) and a decrease of TTC, GEV and Occurrences/s of
map D (p < 0.02) in delta band;
• an increase of TTC of map B (p = 0.0081) and a decrease
of TTC, GEV and Occurrences/s of map D (p < 0.0066) in
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TABLE 5.1: MANOVA (Pillai’s trace)
f p Trace
Broadband Group 6.8672 2.1354e-04 0.8290
[1− 40] Hz Compound 1.4807e+03 0 0.9989
Interaction 2.5305 0.0389 0.6073
Delta band Group 11.9611 5.0534e-06 0.8941
[1− 3.4] Hz Compound 663.6563 0 0.9975
Interaction 13.5025 1.5464e-06 0.8919
Theta band Group 2.4489 0.0448 0.6335
[4− 8.7] Hz Compound 483.7364 0 0.9966
Interaction 2.6232 0.0336 0.6158
Alpha band Group 17.0827 3.7047e-07 0.9234
[9− 12] Hz Compound 858.7760 0 0.9981
Interaction 6.0999 4.0019e-04 0.7885
Beta band Group 7.2614 1.4977e-04 0.8368
[14− 17] Hz Compound 1.2135e+03 0 0.9987
Interaction 4.5466 0.0023 0.7353
theta band; a decrease of TTC and Occurrences/s of map D
(p < 0.0081) in beta band
• finally, an increase of Occurrences/s of map C (p = 0.0047)
and a decrease of TTC and Occurrences/s of map D (p <
0.0081) in beta band
(the false discovery rate was controlled by Benjamini-Hochberg
procedure [127]).
To sum up, we can state that there is an evident and signifi-
cant decrease of TTC and Occurence/s per second of map D dur-
ing HYPO respect to EU in all frequency bands.
68 Chapter 5. Microstate analysis
!"#$ %$&'
()*+$,%$&'
-%.
-/.
-'.
-".
0+"#$,%$&'
1")#$ %$&'
2$* ( 2$* ! 2$* 3 2$* 1
!45$' %$&'
-$.
6"*4"7"&#$#89" #5*5:4$*+8"7
FIGURE 5.4: 4 most representative topographies
for both glycemic conditions in all subjects from
broadband data [1-40] Hz, delta band [1-3.4] Hz,
theta band [4.8-7] Hz, alpha band [9-12] Hz, beta
band [14-17] Hz, named map A, B, C and D, ac-
cording to the microstates literature convention.
Map D displays significant difference in its mi-
crostates parameters in all frequency bands.
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FIGURE 5.5: Results of microstates parameters for
both glycemic conditions in all subjects from data
filtered in: broadband [1-40] Hz, delta [1-3.4] Hz,
theta [4.8-7] Hz, alpha [9-12] Hz and beta [14-17]
Hz EEG frequency bands. Significant differences
between EU and HYPO results are reported by one
star for pvalue ≤ 0.05, two stars for pvalue ≤ 0.01
and three stars for pvalue ≤ 0.001.
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5.4 Discussion
In this chapter, we investigated if there were significant differ-
ences in the time-course of microstates in HYPO compared to EU
in the broadband, delta, theta, alpha and beta frequency range.
We found an evident and significant decrease of TTC and Oc-
currences/s of map D during HYPO respect to EU in all fre-
quency bands. This result might support the hypothesis that the
changes in the frequency domain (Chapter 3) and the decrease of
the EEG signal complexity in HYPO (Chapter 4) have in common
the same resting EEG electric potential amplitude map.
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Chapter 6
Behavioral performance and
correlation among EEG
quantitative features
6.1 State of the art
Recent studies have investigated the relationship between resting-
state slow wave power, healthy aging and cognitive performance
[128]. In particular in [128], authors found that healthy aging was
accompanied by a marked and linear decrease of resting-state ac-
tivity in the slow frequency range, i.e., [0.5 − 6.5] Hz. Moreover,
the effects of slow wave power on cognitive performance were
expressed as interactions with age: for older subjects (> 54 years)
the change in delta and theta power in temporal and central re-
gions was positively associated with perceptual speed and exec-
utive functioning, underlining the important role of slow wave
oscillations in neurocognitive function. The works [129] [130]
[131] [132] supported the hypothesis that neural oscillations co-
ordinate information transfer in the brain, support plasticity pro-
cesses and subserve important perceptual and cognitive func-
tions such as sensory feature binding, speech perception, mem-
ory and attention.
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quantitative features
In this chapter, we want to investigate the cognitive perfor-
mance during HYPO for T1D patients and the relationship with
the increase in power in low frequency bands and the change
in the microstates parameters. The cognitive performance was
not compared to the results of functional connectivity (Chapter
3) and complexity analysis (Chapter 4) because these two analy-
ses were limited to a subset of EEG channels.
6.2 Results
6.2.1 Behavioral performance
All subjects performed the Stroop test and the TMT B during the
three glycemic periods, i.e., EU, HYPO and the recovery after the
period in HYPO. In Fig. 6.1, the results of the cognitive tests for
all subjects are reported. Firstly, we can note that during the re-
covery (light green in Fig. 6.1), the results for each of the tests
are comparable with the results during the period of EU before
entering in HYPO (dark green in Fig. 6.1). Thus, we can state
that the visible patients drop in performance during HYPO was
not due to tiredness (the HYPO interval is about 4 hours after the
start of the experiment in the hospital). Secondly, after applying
paired Student’s t-tests under the hypothesis of normal distri-
bution of samples (Lilliefors test) otherwise, Wilcoxon rank-sign
tests, a significant worsening during HYPO compared to EU was
found in the performance of all the tasks (p < 0.001). In particular
during TMT B, performances deteriorated up to 30% and during
the Stroop test up to 15%, revealing the drop in visual attention,
processing speed and selective attention during HYPO. We also
replicated the analyses by dividing the subjects with and without
awareness of HYPO, but no significant difference in the perfor-
mance for the two groups were found. In Fig. 6.2, we reported
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the results for each of the test for both groups in EU, HYPO and
Recovery.
FIGURE 6.1: In panel (a), on the left, example of
TMT B and, on the right, results of TMT B per-
formance in EU, HYPO and Recovery by T1D pa-
tients. In panels (b, c, d), on the left, example of
Stroop Color and Word Test; on the right, number
of items named correctly by T1D patients in 45 s in
EU, HYPO and Recovery. During HYPO, there is a
significant worsening in the performance of all the
tasks (p<0.001) while EU and Recovery conditions
are comparable.
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FIGURE 6.2: From left to right, results of TMT
B and Stroop test in aware (violet) and unaware
(orange) patients in EU, HYPO and Recovery. In
all conditions, the performance for awareness pa-
tients is comparable with the one of unawareness
subjects. There are not significant differences.
6.2.2 Correlation between cognitive tests and EEG
quantitative measures
The goal of this section is to evaluate if there are any correlations
among the cognitive impairment due to HYPO presented in the
previous section, the altered topography and temporal dynamics
of the brain electric microstates described in Chapter 5, and the
altered power spectra presented in Chapter 3. In particular, we
computed the sample linear partial correlation coefficients r and
their corresponding p-values between:
• the difference (∆) in EU and HYPO of the microstate pa-
rameters that results significantly different between the two
different glycemic conditions;
• the difference in EU and HYPO of the absolute power in the
theta, alpha and beta frequency bands in all electrodes;
• the difference in EU and HYPO of the results of neurocog-
nitive tests;
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while controlling for the effect of age and diabetes duration.
Before computing the correlation among the significant re-
sults obtained in the previous chapters, we controlled if there
were differences in the results between hypo-aware and unaware
patients in the most significant spectral power and microstate pa-
rameters results. As depicted in Fig. 6.3, there was only a light
difference in the overall results between the two groups for mi-
crostates parameters. The difference between EU and HYPO is
more significant in hypo-aware patients (p < 0.01) than in hypo-
unaware ones (p < 0.05). Because of this slight difference in mi-
crostates, we compared all the results in all microstates maps.
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FIGURE 6.3: In panel (a), average power across
all electrodes in theta, alpha (considering only
T5- T6- P3- P4- Pz- O1- O2-A1A2) and beta fre-
quency bands in EU, HYPO in the patients with
hypo-awareness versus the patients with hypo-
unawareness. There is not difference in the over-
all results between the two groups. In panel (b),
results of microstate parameter Occurrences/s for
map D. The difference between EU and HYPO is
more significant in hypo-aware patients (p < 0.01)
than in hypo-unaware ones (p < 0.05).
Although only qualitatively, we found a difference in map C
between aware and unaware patients as depicted in Fig. 6.4.
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FIGURE 6.4: Microstates parameters of map C in
all EEG frequency bands. Generally, Map C seems
to be more present in unaware patients compared
to aware patients during HYPO.
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This result suggests that map C in unaware patients is gener-
ally more present during HYPO in accordance with [133], where
authors showed that map C becomes more dominant when so-
matic awareness is reduced.
In Fig. 6.5 and 6.6, we reported the results between the vari-
ables that resulted significantly correlated. Fig. 6.5 reported the
results of the magnitude of Pearson’s linear correlation coeffi-
cients |r| (colorbar) between the difference in the performance
between EU and HYPO of TMT B and:
(a) the increase in power of theta band;
(b) the increase in power of alpha band;
(c) the decrease in power of the beta band during HYPO in all
electrodes.
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FIGURE 6.5: Results of the magnitude of Pear-
son’s linear correlation coefficients |r| (colorbar)
between the difference in the performance be-
tween EU and HYPO of TMT B and (a) the in-
crease in power of theta band (|r| > 0.53, p < 0.003
in T6 P4 O2); (b) the increase in power of alpha
band (|r| > 0.58, p < 0.001 in T6 P3 P4 Pz O1
O2); (c) the decrease in power of the beta band
(|r| > 0.54, p < 0.003 in F3 F4 P4 O1 O2) during
HYPO in all electrodes.
In particular, we found a significant correlation between the
drop in the TMT B performance and:
(a) the increase in the power of theta band in T6-, P4-, O2-A1A2
EEG channels (|r| > 0.53, p < 0.003);
(b) the increase in power of alpha band in T6-, P3-, P4-, Pz-,
O1-, O2-A1A2 (|r| > 0.58, p < 0.001);
(c) the decrease in power of the beta band in F3-, F4-, P4-, O1-,
O2-A1A2 (|r| > 0.54, p < 0.003).
Fig. 6.6 depicted the results of the magnitude of coefficients |r|
(colorbar) between the decrease of Occurrences/s of map D dur-
ing HYPO:
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(a) in theta band and the increase in power of theta band
(b) in beta band and the decrease in power of beta band during
HYPO in all electrodes.
Specifically, in (a), we found a significant correlation in the EEG
channel Cz-A1A2 (|r| = 0.59 ; p = 0.0007), while in (b) in Fz-,
Cz-A1A2 EEG channels (|r| > 0.52 p < 0.01).
FIGURE 6.6: Results of the magnitude of Pear-
son’s linear correlation coefficients |r| (colorbar)
between the decrease of Occurrences/s of map D
during HYPO: (a) in theta band and the increase in
power of theta band (|r| = 0.59 ; p = 0.0007 in Cz);
(b) in beta band and the decrease in power of beta
band (|r| > 0.52 p < 0.01 in Fz Cz) during HYPO
in all electrodes.
6.3 Discussion
In this chapter, we checked the interaction of the results pre-
sented in the previous Chapters 3 and 5 with the results of the
behavioral tests. The generalize slowing proved by the overall
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increase in the spectral power of low frequency bands influenced
the processing speed and both the visual and selective attention
measured by the behavioral tests. Indeed, we found a direct cor-
relation among the changes in the power spectra, the cognitive
tests performance and the changes in map D, probably due to
the disruption of the cognitive network during HYPO.
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7.1 Main achievements and discussion
Hypoglycemic events in patients affected by T1D were proved to
be associated with measurable EEG changes. In this dissertation,
our aim was to have a more complete overview on the effects of
hypoglycemia in the brain by broaden the EEG analysis in both
the time and frequency domain starting from the literature find-
ings. In particular, we applied our investigation on a database
of hospitalized patients who underwent an hyperinsulinemic-
hypoglycemic clamp for about 8 h.
As long as modern views of neurology and neuroscience state
that the cerebral cortex is based on the dual principle of segrega-
tion and integration, i.e., considering functional segregation, the
attention is focused on distinct brain areas while taking in ac-
count functional integration, the brain does not operate in isola-
tion but by a coordinated activity between different brain areas,
we analyzed the EEG changes due to HYPO by different point
of views, considering different strategies and methods and con-
sidering both all the network and only bipolar EEG channels. In
particular, our work was structured with the following goals:
1. Confirming in our data the same effects of HYPO in the
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EEG signal demonstrated in the literature, i.e., a general-
ized slowing of cerebral activity during episodes of HYPO.
2. Proving if this generalize slowing identified by the increase
in the spectral power of the low frequency bands was also
mirrored in the reduction of EEG complexity, and if it was
possible to measure this EEG feature by means of methods
with low computational cost.
3. Investigating if these changes in the frequency and com-
plexity domains had in common the same resting EEG elec-
tric potential amplitude map.
4. After testing that the state of hypoglycemia influenced the
processing speed and both the visual and selective atten-
tion, searching a direct correlation among the changes in
the power spectra, the cognitive tests performance and the
changes in EEG amplitude maps.
It is qualitatively observable by visual inspection that the EEG
signal in the hypoglycemic condition originates by a process of
higher amplitudes in the low frequency bands and reveals greater
regularity (Chapter 2). Indeed (Chapter 3) relative power in both
theta and alpha bands statistically increases in HYPO respect to
EU. Moreover, the general frequency slowing in HYPO denotes
the shifting to lower frequencies of the centroid frequency in al-
pha band and it is compensated by a significant decrease of power
in beta band. In healthy subjects, theta and alpha rhythms usu-
ally occur during sleep and/or meditative states while beta waves
during alert, problem solving, judgment, decision making, and
mental activity. Thus, the increase in low frequency bands paral-
lel to the decrease in fast rhythms most likely is due to the pro-
gressive loss of cognitive functions during HYPO.
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Actually in our data, this loss of cognitive function during
the pathological state of HYPO is proved by the results of TMT
B and Stroop tests, where patients in HYPO have a drop in the
performance of all the tests. Moreover, how this altered cerebral
activity is mainly due to the entering in HYPO and not merely
due to tiredness is demonstrated by the equal performance in
TMT B and Stroop test in EU before and after the hypoglycemic
period (Chapter 6).
After establishing the influence of HYPO in the low EEG rhy-
thms, we investigated how HYPO affects the connectivity be-
tween different areas. Our analysis was limited to the tempo-
ral, ’central’, parietal, and occipital lobes, because we used raw
EEG data to avoid to distort the analyses as suggested in the lit-
erature. Our results showed that EEG functional connectivity
is affected by hypoglycemia in both the theta and alpha bands.
In particular, the the value of information Partial Directed Co-
herence significantly decreased (p < 0.01) passing from EU to
HYPO from T5-A1A2 to C3-A1A2, from O1-A1A2 to C4-A1A2,
and from O2-A1A2 to Cz-A1A2 in the theta band and from O1-
A1A2 to T4-A1A2 and from O1-A1A2 to C4-A1A2 in the alpha
band. Both T4-A1A2 and O1-A1A2 EEG channels were also in-
volved in the decrease of the value of the centroid frequency in
alpha band. Thus, we found a decrease in the connectivity in the
path from the occipital lobes to the temporal and central lobes
during HYPO (Chapter 3). Probably, the disruption of this piece
of brain network during HYPO is the result of the alterations
of mental and perceptual functions during the critical state of
HYPO. The overall decrease in the value of information Partial
Directed Coherence (even if not significant in all combinations
of EEG channels) probably confirms the hypothesis that the state
of unawareness and unconsciousness due to HYPO disrupts the
functional integration of the brain.
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To deepen on the analysis on the functional reaction of the
brain to HYPO, we also evaluated the degree of complexity tak-
ing in account a pair of EEG channels in the posterior area of
the brain. In neural signals, complexity is high for systems that
contain specialized and organized elements, while it is lower in
system uniform or random. Indeed, during HYPO, the EEG sig-
nal results more regular, more uniform, less complex respect to
EU. This decrease in complexity highlighted by a significant de-
crease of Higuchi’s fractal dimension and an increase of both the
new fractal features proposed in our work, confirms the loss in
cognitive function during HYPO (Chapter 4).
To complete our insight of the brain state during HYPO, we
studied the changes of the brain network dynamics not in the fre-
quency domain, but in the time domain by means of microstates
analysis. EEG-resting state can be decomposed into 100-ms time
epochs with quasi-stable field topography maps, so called mi-
crostates that should correspond to transiently stable distributed
neural networks. In our data, map D displayed the more signifi-
cant differences between the euglycemic and hypoglycemic state.
In particular, the total time covered and the occurrences per sec-
ond of this map during HYPO was lower respect to EU (Chapter
5). Previous studies proved alterations of map D in people with
mental disorders compared to healthy controls where map D had
a significantly longer mean duration and covered a higher per-
centage of time [134]. Because of the knowledge of the functional
significance of different microstate maps still is very limited, we
can only speculate that this evident alteration in map D could be
linked with degraded attentional mechanisms caused by HYPO.
In a recent study, about the interpretation of the psychological
domain described by the microstates maps, they showed that
map C becomes more dominant when somatic awareness is re-
duced [133]. Indeed, comparing the microstates results between
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hypo-aware and unaware subjects, we found qualitatively differ-
ences in the contribution of map C. Probably due to the limited
dataset, we didn’t find statistically differences. While in the fre-
quency and cognitive domains, the differences between the two
groups were not visible, even qualitatively.
Eventually, evaluating the correlation between the EEG quan-
titative measures presented in this work, we discovered a similar
trend between the results of the spectral power changes in theta,
alpha and beta bands and the performance in TMT B and be-
tween the theta and beta power changes and the Occurrences/s
of map D. For the first relationship, we found a significant cor-
relation between the TMT drop in performance and the power
increase of theta and alpha bands and the parallel power de-
crease of beta band in the posterior area of the brain, probably
because this area is responsible for the language and verbal mem-
ory that is involved in the cognitive test. While the drop in the
Occurrences/s of map D was correlated with the increase in theta
power and the decrease of beta power in the central region of the
brain, supposed to be the area involved in the cognitive network
that seems to be disrupted during HYPO.
7.2 Future challenges
In this study, we proved that the well-known low-frequency power
increase is specific to a unique large-scale brain network which
spatial characteristics still remain to be elucidated by using high-
density EEG and electrical source imaging (ESI). ESI is a model-
based imaging technique that integrates temporal and spatial com-
ponents of EEG to identify the generating source of electrical
potentials recorded on the scalp [135]. This technique needs an
high number of electrodes and possibly, a co-registration of elec-
trode positions on MRI [136]. Identifying the electrical source of
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the topographies found during EU and HYPO might help in un-
derstanding how the brain is affected by HYPO. Moreover, this
technique might validate and deepen the neurological interpreta-
tion of the results. Furthermore, the results interpretation could
improve by applying the methods presented in this work in ex-
tended databases.
Previous studies reported that EEG changes in HYPO sug-
gest a possible use of the brain as a biosensor to detect hypo-
glycemia in T1D through EEG monitoring by subcutaneous elec-
trodes (with a potential lifetime of several years) and real-time
data processing by means of a multi-parameter algorithm [35].
With regard to this aspect, the accuracy achieved in this study
may seem far from ideal, but a further investigation of the po-
tential usefulness of EEG in detecting hypoglycemia is still war-
ranted. The benefit of EEG as a biomarker is that the hypoglycemia
associated EEG changes are not blunted during hypoglycemia
in patients with hypoglycemia unawareness, in contrast to the
symptom of hypoglycemia, the counterregulatory hormonal re-
sponse, and skin temperature changes. By using EEG signals as
the measuring principle there is a direct correlation between on-
coming hypoglycemia and the signal that is measured. In this
way, the measurement principle will be not affected by delays
and other unintended transition functions. Furthermore, a fre-
quent calibration as in blood glucose sensors is not required to
identify the characteristic hypoglycemia pattern. In particular,
authors in [35] focused on the possibility to construct a hypo-
glycemia alarm system based on continuous EEG monitoring and
real-time data processing by means of a multi-parameter algo-
rithm based on four levels, Fig. 7.1. At the first level, the fea-
ture extraction based on frequency, amplitude and power of 1-
s EEG epoch processes the raw EEG to distinguish EEG altered
by hypoglycemia from normal EEG. The second level consists of
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three blocks, each of which analyses the features to determine if
there is evidence of impending hypoglycemia, deep sleep pat-
terns, or noise contamination, respectively. At the third level,
EEG epoch is labeled as consistent or not-consistent with hypo-
glycemia. Lastly, taking the recent history into account it is de-
termined whether or not a sufficient amount of hypoglycemia
evidence is present to constitute an alarm. An EEG-based hy-
poglycemia detection device, however, still needs to be tested in
a clinical setting. Certainly, fundamental issues, such as sensi-
tivity, specificity, reliability, resolution, and influence of activity,
must be carefully addressed before demonstrating a real-time us-
ability of such a device. Furthermore, each level of the algorithm
presented in Fig. 7.1 should be validated in an extended database
and the margins of improvement of each level should be carefully
addressed.
FIGURE 7.1: Structure of the hypoglycemia detec-
tion algorithm. Reproduced from [35].
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